[{"authors":[{"objectId":"61ea28b875234061bbd3c299","name":"Łukasz","lastName":"Hajac","uuid":"EA26F3284EC4D1F80D0DC0B6348F0441522B1751634A9E957422A4EF155785849782886B72BBA743B7E22514666AFEC5A1119FD266DC15020395DC791D6CF60C","documentHash":"129252f0-3729-454f-a93d-cac93c928837"}],"objectId":"63d65b76409707538293b86c","publicUri":"https://journals.viamedica.pl/onkologia_w_praktyce_klin_edu/article/view/92991","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"Długotrwała odpowiedź na terapię kabozantynibem pomimo konieczności znacznej redukcji dawek leku","otherTitles":[],"abstracts":[{"languageCode":"pol","content":"Rak nerki stanowi kilka procent zachorowań na nowotwory. Choroba zaawansowana pozostaje z reguły nieuleczalna, jednak dzięki nowoczesnym metodom leczenia systemowego przeżycie chorych można znacząco wydłużyć. Leczenie inhibitorami kinaz tyrozynowych może powodować działania uboczne pogarszające jakość życia chorych, ale dzięki dobremu leczeniu wspomagającemu i dostosowaniu dawkowania leczenie utrzymać z dobrą wieloletnią kontrolą choroby, niekiedy osiągając nawet znaczną regresję zmian. Opis przypadku chorego leczonego pazopanibem i kabozantynibem."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c299"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"pol","mainLanguageName":"polski","volume":"8","issue":"Supl. D","pagesFromTo":"3-5","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["61ea28b875234061bbd3c299"]},"journal":{"objectId":"5e6f7d5b878c28514547ce1f","mniswId":"15394","title":"Oncology in Clinical Practice","issn":"2450-1654","eissn":"2450-6478","metadataSource":"WOS","documentHash":"e2d9e3ec-c5c7-4e69-ba15-6568232bff35"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"pol","keywords":["rak nerkowokomórkowy,","kabozantynib,","dostosowanie dawki"]}],"lastRefresh":"1747058467363"},{"authors":[{"objectId":"6630c69b4097076263e7aa61","name":"Piotr","lastName":"Kasprzak","documentHash":"69d61bc0-ddf0-4708-9827-510345745e94"},{"objectId":"6630c69b4097076263e7aa60","name":"Małgorzata","lastName":"Bandyk","documentHash":"56321381-cdfe-429e-9a9d-af6b5e0e177c"},{"objectId":"6630c69b4097076263e7aa5f","name":"Marcin","lastName":"Celer","documentHash":"a1c190cb-de45-4366-a5e4-a29de5b76c84"},{"objectId":"6630c69b4097076263e7aa5e","name":"Mateusz","lastName":"Koziej","documentHash":"d94ce54d-618f-4359-bcac-6866e4136926"},{"objectId":"6630c69b4097076263e7aa5d","name":"Hanna","lastName":"Marszalska-Jacak","documentHash":"04ce47e4-2186-4d7a-bbc9-7ee1f8d92fe9"},{"objectId":"6630c69b4097076263e7aa5c","name":"Michał","lastName":"Lis","documentHash":"401887a1-4402-44f4-b046-7fbcce50640f"},{"objectId":"5e7094c7878c28a0473c37fb","name":"Bartłomiej","lastName":"Szynglarewicz","uuid":"5DAAF83019AE2010BC98A6D1989198209BE5435FE5FCAD759DC83AAC559DE1A4918A57F63D40C9C4422464ED648479B0BD079099196A34C3D77C433922EF4647","orcidId":"0000-0002-1153-5647","documentHash":"58c6fb12-901d-49dd-ab3e-cce619384c0d"},{"objectId":"5e709459878c28a0473bb1c5","name":"Bartosz","lastName":"Dołęga-Kozierowski","uuid":"5729047AEC3177ACE97AB34DF58D908E43F299EF0D8F14464F6567D95DE56E65B08D0F1C1E8183FD64BAFC392CBD0534EC6CC480C9D6837B42AF534965D3D491","documentHash":"5d144a7f-1391-411b-9c9a-769226bfe6ec"},{"objectId":"5e70930a878c28a0473a1aa4","name":"Rafał","lastName":"Matkowski","uuid":"99B055AD582A83F9ACCB46B5F13634676074A0964285A2AB8B93FB85907E2BE1B0B0A5E9FA3897E4D6B6B080AC9718B512ADE08CC059FDDC75BB60C52873C7CE","orcidId":"0000-0002-1705-5097","documentHash":"fc9ac5b6-d872-46ba-b830-b2be4efcaf8d"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2022-08-22","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"63d658b24097075382939bed","doi":"10.3389/fonc.2022.855519","publicUri":"https://www.frontiersin.org/articles/10.3389/fonc.2022.855519/full","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"Multimodality imaging in lobular breast cancer: differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristics","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Introduction: Invasive lobular breast cancer (ILC) is a diagnostic challenge due to the diversity of morphological features. The objective of the study was to investigate the presentation and local extent of ILC using various imaging techniques and to assess the correlation between imaging and molecular profile.\r\nMaterials and methods: We reviewed 162 consecutive patients with ILC found on vacuum-assisted biopsy, who underwent evaluation of the lesion morphology and extent using ultrasound (US), mammography (MMG), and magnetic resonance imaging (MRI). Radiographic features were compared with ILC intrinsic subtype based on the expression of Ki-67 and estrogen, progesterone, and HER2 receptors.\r\nResults: A total of 113 mass lesions and 49 non-mass enhancements (NMEs) were found in MRI. Masses were typically irregular and spiculated, showing heterogeneous contrast enhancement, diffusion restriction, and type III enhancement curve. NMEs presented mainly as the area of focal or multiregional distribution with heterogeneous or clumped contrast enhancement, diffusion restriction, and type III enhancement curve. Lesion extent significantly varied between MRI and MMG/ultrasonography (USG) (P < 0.001) but did not differ between MGF and ultrasonography (USG). The larger the ILC, the higher the disproportion when lesion extent in MRI was compared with MMG (P < 0.001) and ultrasonography (USG) (P < 0.001). In the study group, there were 97 cases of luminal A subtype (59.9%), 54 cases of luminal B HER2- (33.3%), nine cases of luminal B HER2+ (5.5%), and two cases of triple negative (1.2%). The HER2 type was not found in the study group. We did not observe any significant correlation between molecular profile and imaging.\r\nConclusion: MRI is the most effective technique for the assessment of ILC local extent, which is important for optimal treatment planning. Further studies are needed to investigate if the intrinsic subtype of ILC can be predicted by imaging features on MRI."}],"affiliations":[{"id":"5e70918b878c28a04737de56","uid":"bHhhRrJPOI9BMfGA4x5cmvQ","uuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","name":"Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu","affiliatedPersonIDs":["5e70930a878c28a0473a1aa4","5e7094c7878c28a0473c37fb"],"parentId":"5e70918b878c28a04737de56","parentUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","rootId":"5e70918b878c28a04737de56","rootUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["5e709459878c28a0473bb1c5"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"12","pagesFromTo":"art.855519 [14 s.]","contributionOrder":{"AUTHOR":["5e709459878c28a0473bb1c5","6630c69b4097076263e7aa5c","6630c69b4097076263e7aa5d","6630c69b4097076263e7aa5e","6630c69b4097076263e7aa5f","6630c69b4097076263e7aa60","6630c69b4097076263e7aa61","5e7094c7878c28a0473c37fb","5e70930a878c28a0473a1aa4"]},"journal":{"objectId":"5e6f7d52878c285145479e71","mniswId":"6858","title":"Frontiers in Oncology","issn":"2234-943X","metadataSource":"IMPORT","documentHash":"e7d53015-2275-4082-9464-9c48d76ae67d"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["breast cancer","invasive lobular carcinoma (ILC)","invasive lobular breast cancer","magnetic resonance imaging","multimodality imaging","lobular breast cancer"]}],"lastRefresh":"1747058491380"},{"authors":[{"objectId":"61ea28b875234061bbd3c299","name":"Łukasz","lastName":"Hajac","uuid":"EA26F3284EC4D1F80D0DC0B6348F0441522B1751634A9E957422A4EF155785849782886B72BBA743B7E22514666AFEC5A1119FD266DC15020395DC791D6CF60C","documentHash":"129252f0-3729-454f-a93d-cac93c928837"},{"objectId":"61ea28b875234061bbd3c236","name":"Zbyszko","lastName":"Chowaniec","uuid":"54CC591F8C269EC4C57FC517848C3ABCF0564604C8025367083DE16B8EA54235FDC0526AFDA0CE64BCEFEC27374B88B0DA18311D9373455356958EC108176523","documentHash":"d5b87a0d-df08-4ad4-8a94-251085c4a374"}],"objectId":"63d64f1e409707538293277c","publicUri":"https://journals.viamedica.pl/onkologia_w_praktyce_klin_edu/article/view/92998","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"Długotrwała i całkowita odpowiedź na leczenia kabozantynibem w drugiej linii leczenia pacjenta z zaawansowanym rakiem nerki","otherTitles":[],"abstracts":[{"languageCode":"pol","content":"Możliwości leczenia raka nerki, w szczególności w IV stopniu zaawansowania, w ostatnich latach uległy znacznej poprawie ze względu na wprowadzenie do terapii leków celowanych oraz inhibitorów punktów kontrolnych. Lekiem o udowodnionej skuteczności w pierwszej, drugiej oraz kolejnych liniach leczenia jest kabozantynib (doustny inhibitor kinaz tyrozynowych). W pracy przedstawiono przypadek chorego z rozpoznaniem jasnokomórkowego raka nerki w IV stopniu zaawansowania, u którego leczenie kabozantynibem w połączeniu z użyciem metod leczenia miejscowego pozwoliło na uzyskanie całkowitej i długotrwałej odpowiedzi."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c299","61ea28b875234061bbd3c236"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"pol","mainLanguageName":"polski","volume":"8","issue":"Supl. D","pagesFromTo":"22-24","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["61ea28b875234061bbd3c236","61ea28b875234061bbd3c299"]},"journal":{"objectId":"5e6f7d5b878c28514547ce1f","mniswId":"15394","title":"Oncology in Clinical Practice","issn":"2450-1654","eissn":"2450-6478","metadataSource":"WOS","documentHash":"e2d9e3ec-c5c7-4e69-ba15-6568232bff35"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747058491422"},{"authors":[{"objectId":"6451c72a40e3ff38f8b2c5ad","name":"Agata","lastName":"Sałek-Zań","uuid":"06D6AB613EACFA1AADCAD5CD76D4192F259AB217A9CBAB79EB49443EE886A7B9E0403D2B42DB6BE2F4D9F44FFCF5925A72A9B676DB7E0EC0156D8BBE5772CAFA","documentHash":"3eb19ca3-1122-4ad5-974e-d5722153e73a"},{"objectId":"642bca2c4097077d1441a62d","name":"Iwona","lastName":"Skoneczna","documentHash":"0f6b11dd-4be1-4765-8202-ee2a021a6a2c"},{"objectId":"642bca2c4097077d1441a628","name":"Kamil","lastName":"Kuć","documentHash":"8f1f75b5-baf4-46f1-a975-c925c77ddebb"},{"objectId":"642bca2c4097077d1441a627","name":"Katarzyna","lastName":"Czerko","documentHash":"1fee935d-7076-4159-bd39-14785f50b9d2"},{"objectId":"642bca2c4097077d1441a625","name":"Joanna","lastName":"Kiszka","documentHash":"fdc66416-0e42-4900-89e0-596025b2cd7d"},{"objectId":"642bca2c4097077d1441a623","name":"Angelika","lastName":"Gawlik-Urban","documentHash":"570828d2-64d5-4fdb-b922-085b4e2e42e5"},{"objectId":"642bca2c4097077d1441a622","name":"Michał","lastName":"Wilk","documentHash":"ba710ede-d0f9-464d-ba38-4186afc722ae"},{"objectId":"61ea28b875234061bbd3c281","name":"Emilia","lastName":"Filipczyk-Cisarż","uuid":"5F0CC9CBBBE59951DC3EACEF09D88D0EF6B7E21F3F62DF0A15F5021EAF8A6893E894F2416B9A11DB606A638688EEC0DD235C55093F60B5AC42ACD5EC886366D8","documentHash":"8ed923f7-580d-4faa-898d-8fccc3167166"},{"objectId":"61ea28b875234061bbd3c227","name":"Mateusz","lastName":"Malik","uuid":"E10C5FF6B24F9CB3F38E63DAE9909766E2F3D709424B581C90C3872E6FBE84412764D5FC8754E23364225C5F44C9D53E3CFAC24320E755E9F2A13213197E48D6","documentHash":"5b20b002-b90f-4ba9-a4a6-f02935e0ea43"},{"objectId":"5e7094f9878c28a0473c828b","name":"Dawid","lastName":"Sigorski","uuid":"C7005E87C7352C850296E74E8AE445E068ABEFCECAE081C3CA807228552E327BECE0C38DC6F2BE682ADCF6F8572E0BF9307C85301521D79738BE2D3F43A4DCFB","orcidId":"0000-0002-4799-9611","documentHash":"c44304ef-a2e3-4cef-86ab-a2f2ce00e7b5"},{"objectId":"5e709481878c28a0473be937","name":"BOŻENA","lastName":"CYBULSKA-STOPA","uuid":"CD3D8AE141276A52832986C177D4BCE5D21E40DE282E327EEB31C1EE86B70664B89A5726AF002249E4297B420E8DFEEA93F87E02DCEEBD4A49D5301AE77FAD47","orcidId":"0000-0002-0975-850X","documentHash":"f5b43596-c5f0-40de-9e00-662ce7929f14"},{"objectId":"5e709431878c28a0473b7f2f","name":"Tomasz","lastName":"Kubiatowski","uuid":"4548F02CD345CDD68F8050B95AF08EBB5FA35C64FA0677425F16AF3B8A5132DEDF1ACB0A9072B47956B367436982CEB07984F3C9AF43D6DAB33037EE48B7A3AA","documentHash":"377747c7-76ba-4b0e-a0a8-a404eba37bfd"},{"objectId":"5e7093f5878c28a0473b404b","name":"Lubomir","lastName":"Bodnar","uuid":"E27FCD39928F7C05FFAD3029B8ED93BA48503D1C860E67CE938DB4FFE7C18285D321CC4D8CB0BF5A87D12D33ED1F6AEF201F69D2DE93FB34448F4B98D7484587","orcidId":"0000-0001-8548-8778","documentHash":"b8e08578-8def-4294-b4a8-f28c94bd98f0"},{"objectId":"5e7093ba878c28a0473afe32","name":"Cezary","lastName":"Szczylik","uuid":"B92DD5FCFFCC06B2E4F39C966B36EE8D4960F5485C94995C3DE41539B7ED70E40457E7A037704E4520E28DC34E942161581974F848677B380DF9206C9A1C50D1","documentHash":"5c7809a5-e064-4d34-8c03-1e39f6f0b33c"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2023-04-03","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"642bca2c4097077d1441a621","doi":"10.3389/fonc.2023.1108937","publicUri":"https://www.frontiersin.org/articles/10.3389/fonc.2023.1108937","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Background: Abiraterone acetate (ABI) and Enzalutamide (ENZA) are second-generation hormone drugs that show breakthrough activity in post-chemotherapy, metastatic castration-resistant prostate cancer (mCRPC). The leading oncological and urological guidelines indicate both drugs with the same strong recommendation. There is a lack of randomized trials which compare the efficacy of ABI and ENZA. The current study aimed to compare the effectiveness of the drugs with an analysis of prognostic factors related to those drugs.\n\nPatients and methods: The study included 420 patients with docetaxel (DXL) pretreated mCRPC from seven Polish cancer centers. Patients were treated according to inclusion and exclusion criteria in the Polish national drug program (1000 mg ABI and 10 mg prednisone, n=76.2%; ENZA, 160 mg; n=23.8%). The study retrospectively analyzed the overall survival (OS), time to treatment failure (TTF), PSA 50% decline rate (PSA 50%) and selected clinic-pathological data.\n\nResults: In the study group, the median OS was 17 months (95% CI: 15.6-18.3). The median OS (26.1 vs. 15.7 mo.; p<0.001), TTF (14.2 vs. 7.6 mo.; p<0.001) and PSA 50% (87.5 vs. 56%; p<0.001) were higher in ENZA than in ABI treatment. Multivariate analysis shows that ENZA treatment and PSA nadir <17.35 ng/mL during or after DXL treatment were related to longer TTF. ENZA treatment, DXL dose ≥750 mg, PSA nadir <17.35 ng/mL during or after DXL treatment was related to longer OS.\n\nConclusions: ENZA treatment may be related to more favorable oncological outcomes than ABI treatment in the studied Polish population of patients. A 50% decline in PSA is an indicator of longer TTF and OS. Due to the non-randomized and retrospective nature of the analysis, the current results require prospective validation."}],"affiliations":[{"id":"5e70918a878c28a04737de1f","uid":"bFstCP-XVgvi8lydtQE33_w","uuid":"1a88b2ad-f6fd-4e5a-b514-27766a21594d","name":"Uniwersytet Warmińsko-Mazurski w Olsztynie","affiliatedPersonIDs":["5e7094f9878c28a0473c828b","5e709431878c28a0473b7f2f"],"parentId":"5e70918a878c28a04737de1f","parentUuid":"1a88b2ad-f6fd-4e5a-b514-27766a21594d","rootId":"5e70918a878c28a04737de1f","rootUuid":"1a88b2ad-f6fd-4e5a-b514-27766a21594d","type":"AUTHOR"},{"id":"5e70918b878c28a04737deca","uid":"bfUR7pyerT3GiQw3TRkatRw","uuid":"69cad015-151b-4fe2-a54c-81c2fd2168e5","name":"Centrum Medyczne Kształcenia Podyplomowego w Warszawie","affiliatedPersonIDs":["5e7093ba878c28a0473afe32"],"parentId":"5e70918b878c28a04737deca","parentUuid":"69cad015-151b-4fe2-a54c-81c2fd2168e5","rootId":"5e70918b878c28a04737deca","rootUuid":"69cad015-151b-4fe2-a54c-81c2fd2168e5","type":"AUTHOR"},{"id":"5e70918b878c28a04737decc","uid":"b-COLbcdAG-k5w4OvZzdVBg","uuid":"bdcdbaed-bbf2-43bd-b224-c5d80dd351fb","name":"Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy","affiliatedPersonIDs":["6451c72a40e3ff38f8b2c5ad","5e709481878c28a0473be937"],"parentId":"5e70918b878c28a04737decc","parentUuid":"bdcdbaed-bbf2-43bd-b224-c5d80dd351fb","rootId":"5e70918b878c28a04737decc","rootUuid":"bdcdbaed-bbf2-43bd-b224-c5d80dd351fb","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c281","61ea28b875234061bbd3c227"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"},{"id":"5e70918b878c28a04737de3b","uid":"bz_6XXECFL3_CFkpms5BsDQ","uuid":"dacccb40-e3e3-4113-a28e-54c4a59d550e","name":"Uniwersytet w Siedlcach","affiliatedPersonIDs":["5e7093f5878c28a0473b404b"],"parentId":"5e70918b878c28a04737de3b","parentUuid":"dacccb40-e3e3-4113-a28e-54c4a59d550e","rootId":"5e70918b878c28a04737de3b","rootUuid":"dacccb40-e3e3-4113-a28e-54c4a59d550e","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"13","pagesFromTo":"1-13","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["5e7094f9878c28a0473c828b","642bca2c4097077d1441a622","642bca2c4097077d1441a623","6451c72a40e3ff38f8b2c5ad","642bca2c4097077d1441a625","61ea28b875234061bbd3c227","642bca2c4097077d1441a627","642bca2c4097077d1441a628","5e7093ba878c28a0473afe32","5e709431878c28a0473b7f2f","61ea28b875234061bbd3c281","5e7093f5878c28a0473b404b","642bca2c4097077d1441a62d","5e709481878c28a0473be937"]},"journal":{"objectId":"5e6f7d52878c285145479e71","mniswId":"6858","title":"FRONTIERS IN ONCOLOGY","issn":"2234-943x","eissn":"2234-943x","documentHash":"ef100815-201e-4659-9c88-713608e7f1bd"},"_version":4,"journalIssue":{"objectId":"63e0c91240970740cdc6028b","year":"2023","volume":"13","documentHash":"585f29c4-eb14-4142-873e-cd51f93047d8"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["Real-world study","Abiraterone acetate","Enzalutamide","Metastatic prostate cancer","Targeted therapy"]}],"lastRefresh":"1747058556956"},{"authors":[{"objectId":"61ea28b875234061bbd3c299","name":"Łukasz","lastName":"Hajac","uuid":"EA26F3284EC4D1F80D0DC0B6348F0441522B1751634A9E957422A4EF155785849782886B72BBA743B7E22514666AFEC5A1119FD266DC15020395DC791D6CF60C","documentHash":"129252f0-3729-454f-a93d-cac93c928837"}],"objectId":"63d65ac2409707538293b44b","publicUri":"https://journals.viamedica.pl/onkologia_w_praktyce_klin_edu/article/view/92997","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"Wspólne mianowniki w diagnostyce i leczeniu raka nerki oraz guza neuroendokrynnego","otherTitles":[],"abstracts":[{"languageCode":"pol","content":"Chorzy z więcej niż jednym procesem nowotworowym stanową pewien odsetek pacjentów onkologicznych. W tych przypadkach wybiera się leczenie potencjalnie aktywne w obu procesach rozrostowych, szczególnie, kiedy jednoznaczna weryfikacja histopatologiczna jest trudna. Zaprezentowano opis przypadku chorej z rozsianym rakiem nerkowokomórkowym leczonej sunitynibem, a następnie kabozantynibem, u której najprawdopodobniej występował również proces z grupy nowotworów neuroendokrynnych. Nietypowy w tej sytuacji był wychwyt w badaniu obrazowym receptorów somatostatyny występujący także w potwierdzonych histopatologicznie przerzutach raka nerkowokomórkowego. Zadowalające były efekty leczenia obu linii, potencjalnie aktywnych w obydwu tych nowotworach, przy akceptowalnych i kontrolowanych toksycznościach."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c299"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"pol","mainLanguageName":"polski","volume":"8","issue":"Supl. D","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["61ea28b875234061bbd3c299"]},"journal":{"objectId":"5e6f7d5b878c28514547ce1f","mniswId":"15394","title":"Oncology in Clinical Practice","issn":"2450-1654","eissn":"2450-6478","metadataSource":"WOS","documentHash":"e2d9e3ec-c5c7-4e69-ba15-6568232bff35"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"pol","keywords":["rak nerkowokomórkowy,","guz neuroendokrynny,","analogi somatostatyny,","kabozantynib,","oktreotyd"]}],"lastRefresh":"1747058628624"},{"authors":[{"objectId":"61ea28b875234061bbd3c271","name":"Izabella","lastName":"Dębicka","uuid":"1BD51D0CE20DFBECAB2C2C956743D20483BE7260EDC9136ED0B72F90D95C925FB59CF6F9956BA29D1AB935A65160F0B07E9A6B157F7C9596DC1B6417C1997503","documentHash":"8d2474af-3503-4b29-973b-2c39ebc537b8"},{"objectId":"607017089543c745d80e5c25","name":"Aleksandra","lastName":"Sztuder","uuid":"17333AA9D467B45FC48E8855C2BF49D75A2B97D7D4ADE0998C9669B48AB6C7C36007597D678DBDD4A9B7926E475A10450823724BC4248530752EB1A733E64F03","orcidId":"0000-0002-1755-0696","documentHash":"fd88314b-9763-47da-b977-bc84edad22d4"},{"objectId":"5e7094c7878c28a0473c38cd","name":"Łukasz","lastName":"Trembecki","uuid":"FC61B8DF2B78E133A4E2FDF015F524B5B4243F66AAAA05D2D6BA2FA6761F72235C268432CB078B1D2202E2768B0A09AE002ED0A56205A64AA6BCF2628FD10B70","orcidId":"0000-0003-0762-6519","documentHash":"ad1325db-6ce5-4ef7-b019-1faa5a4e1d84"},{"objectId":"5e709433878c28a0473b7ff1","name":"Adam","lastName":"Maciejczyk","uuid":"4951FC5582B451CF799238B3FB3507897BB1EDCC864B23E491946D759689D1C0DE7AD290F819B8A1789355EBE6E120C746392BA55E14C7DDD1DDA53BB9150767","orcidId":"0000-0002-7047-0433","documentHash":"cef045e4-3574-43d6-8f3d-1baed9fedb48"},{"objectId":"5e70930a878c28a0473a1aa4","name":"Rafał","lastName":"Matkowski","uuid":"99B055AD582A83F9ACCB46B5F13634676074A0964285A2AB8B93FB85907E2BE1B0B0A5E9FA3897E4D6B6B080AC9718B512ADE08CC059FDDC75BB60C52873C7CE","orcidId":"0000-0002-1705-5097","documentHash":"fc9ac5b6-d872-46ba-b830-b2be4efcaf8d"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2022-08-31","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"63d650af409707538293300d","doi":"10.1186/s12885-022-10020-9","publicUri":"https://bmccancer.biomedcentral.com/articles/10.1186/s12885-022-10020-9","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"The pilot project of the National Cancer Network in Poland: Assessment of the functioning of the National Cancer Network and results from quality indicators for lung cancer (2019–2021)","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Background: This analysis presents the outcomes of the operations of the National Cancer Network (NCN) pilot project in Lower Silesian Voivodeship, Poland, for lung cancer for the period of 2019–2021. The results concerning measures of the quality of medical processes were analysed. Methods: Twenty-one measures used to gauge the quality of oncological care for lung cancer were assessed. Data collection and processing for the purpose of calculating the measures were carried out as part of the NCN pilot project based on the Regulation of the Ministry of Health enacted on 13 December 2018. The measures were calculated at the Voivodeship Coordination Center, and the data were derived from the centres included in the network in the area of the analysed voivodeship.</jats:p>\r\n              </jats:sec><jats:sec>\r\n                <jats:title>Results</jats:title>\r\n                <jats:p>A total of 3,638 patients diagnosed with lung cancer were enrolled in the NCN pilot program during the analysed period. For 3 measures, out of 21, target values were obtained. For 2 measures, the values differed significantly from the assumed target value.</jats:p>\r\n              </jats:sec><jats:sec>\r\n                <jats:title>Conclusion</jats:title>\r\n                <jats:p>In our opinion, the NCN pilot study, as a test of the network’s functioning, meets the assumed goal. The NCN assessment is based on, inter alia, analysis of the outcomes of oncological quality of care measures for lung cancer, and facilitates monitoring of the quality of medical services provided and the identification of areas for improvement. In addition, the pilot program, which will last until the end of 2022, will allow for further in-depth analysis regarding the network’s limitations before implementing the system on a national scale in Poland. This will be the subject of further investigation."}],"affiliations":[{"id":"5e70918b878c28a04737de56","uid":"bHhhRrJPOI9BMfGA4x5cmvQ","uuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","name":"Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu","affiliatedPersonIDs":["5e70930a878c28a0473a1aa4","607017089543c745d80e5c25","5e709433878c28a0473b7ff1","5e7094c7878c28a0473c38cd"],"parentId":"5e70918b878c28a04737de56","parentUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","rootId":"5e70918b878c28a04737de56","rootUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c271"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"22","issue":"1","pagesFromTo":"art.939 [10 s.]","contributionOrder":{"AUTHOR":["5e7094c7878c28a0473c38cd","5e70930a878c28a0473a1aa4","5e709433878c28a0473b7ff1","607017089543c745d80e5c25","61ea28b875234061bbd3c271"]},"journal":{"objectId":"5e6f7d4a878c2851454773c2","mniswId":"2603","title":"BMC Cancer","issn":"1471-2407","metadataSource":"SCOPUS","documentHash":"28d20864-24c5-427c-9a42-ddc11f14878d"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["Lung cancer","Poland","National Cancer Network"]}],"lastRefresh":"1747058629210"},{"authors":[{"objectId":"61ea28b875234061bbd3c296","name":"Anna","lastName":"Latajka","uuid":"8B3623C14F3CBB32A57622FB9280DAC519CC769404EDCF316EDABEA588AA23E43F6AE3EDE1340B5235FE03FA7B1A98133D4396110D811F0125B296D9C11F9FC5","documentHash":"12da589a-f7d7-4895-a5c0-1a2fb85c6360"},{"objectId":"5e709261878c28a047394b6a","name":"Iwona","lastName":"Malicka","uuid":"0EA14EB6FE9155A7A5EA5D4EA645558C95BCA7ACBB4F3DDF01DA482827CCDA11B89D2BC045D9EB45983ABAFAAE7751A7A03579EC33E58483EA2D5E1BD4F685EF","orcidId":"0000-0002-7668-001X","documentHash":"cedbcb64-7d82-402f-9e0c-fe5e057e8a32"},{"objectId":"5e709261878c28a047394b3f","name":"Małgorzata","lastName":"Stefańska","uuid":"FF4262BB2960DAB73FDE64EEF3CB773B1E9EFD0F6DE9E93447602B4703CB993051E20D3654F812AB541DF22ED48FB43DE949B6ED720001EA26391261591DE61B","orcidId":"0000-0003-2070-8535","documentHash":"8a841b43-c469-442e-a109-64f8629b5584"},{"objectId":"5e70924f878c28a0473936eb","name":"Marek","lastName":"Woźniewski","uuid":"65B35419D6BEBB37BBBD11BC75FEA497FF3FD9EEAD5CD6DF027EE0C8D53B3E8400472697EDB2472916A13FC1E89C92062C267A81A7D8D536E3A9CF33BB7CC37C","orcidId":"0000-0002-8241-7808","documentHash":"07465ae2-d5f9-4000-9b06-492d1d220fb2"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2023-11-30","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"6569b8404097077c04774208","doi":"10.3390/healthcare11233069","publicUri":"https://www.mdpi.com/2227-9032/11/23/3069/pdf","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Walking Speed and Risk of Falling Patients Operated for Selected Malignant Tumors","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Background: A literature review reveals that studies on walking and fall occurrences in the context of cancer have predominantly centered on geriatric patients. Nonetheless, cancer patients of all ages are susceptible to such risks. Both cancer and its treatments contribute to significant risk factors for disturbances in walking and falls, encompassing muscle weakness, impaired balance, reduced proprioception, cognitive impairment, and functional limitations. Aim: to assess walking speed and the risk of falls among patients undergoing surgery for the most common malignancies: breast (BU), lung (P), colorectal (DS), and reproductive organs (G). Material and Methods: An observational study was conducted using a cohort design. A total of 176 individuals participated in the study, including 139 cancer patients, who were divided into four groups: BU (N = 30), P (N = 35), DS (N = 35), and G (N = 39), as well as 37 healthy volunteers in the control group (C, N = 37). All participants underwent an assessment of walking speed using BTS G-WALK® and an evaluation of the number of falls and the risk of falling using a Fall Control Card. Results: There was a significant decrease in walking speed after surgery compared to the time before surgery, from 2.7% in the BU group, through 9.3% in the P group, and 19.2% in the DS group, to 30.0% in the G group. At the same time, for groups G and DS, the average walking speed fell below 1.0 m/s, amounting to 0.84 m/s and 0.97 m/s, respectively, in the measurement after the surgery and 0.95 m/s and 1.0 m/s in the follow-up measurement. Falling occurred in all the groups except for the BU group. The created logistic regression model showed that increasing the walking speed measured after the procedure (study 2) by 1 m/s reduces the risk of falling by approximately 500 times (OR = 0.002). Limitations in daily activity were observed in the follow-up examination (study 3) in 75% of patients. Conclusions: Surgical intervention has an impact on walking speed, and being part of the study group influences the risk of falling. Further research is needed to determine the precise risk of falls in cancer patients."}],"affiliations":[{"id":"5e70918b878c28a04737de4d","uid":"bfV9s5tJVMHwc1Lo8md7ngA","uuid":"04496ff8-47c8-4c64-af60-278a7de9d867","name":"Akademia Wychowania Fizycznego im. Polskich Olimpijczyków we Wrocławiu","affiliatedPersonIDs":["5e709261878c28a047394b6a","5e709261878c28a047394b3f","5e70924f878c28a0473936eb"],"parentId":"5e70918b878c28a04737de4d","parentUuid":"04496ff8-47c8-4c64-af60-278a7de9d867","rootId":"5e70918b878c28a04737de4d","rootUuid":"04496ff8-47c8-4c64-af60-278a7de9d867","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c296"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"11","issue":"23","pagesFromTo":"art. 3069, s. 1-12","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["61ea28b875234061bbd3c296","5e709261878c28a047394b3f","5e70924f878c28a0473936eb","5e709261878c28a047394b6a"]},"journal":{"objectId":"5e6f7d58878c28514547c297","mniswId":"7474","title":"Healthcare","issn":"2227-9032","eissn":"2227-9032","metadataSource":"WOS","documentHash":"34534031-29f6-4f99-8f1c-2119803c11e4"},"_version":4,"journalIssue":{"objectId":"6566f9f340970767abd35a84","year":"2023","volume":"11","number":"23","documentHash":"0c386213-f8b0-41ad-a263-e2665a16d916"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["cancer","surgical treatment","walking speed","fall risk"]}],"lastRefresh":"1747059056353"},{"authors":[{"objectId":"67236c68fdbe8307b0e19d47","name":"Soliński","lastName":"Daniel G","documentHash":"3713410a-c9f3-4e79-8c67-cc8c72f23b30"},{"objectId":"67236c68fdbe8307b0e19d46","name":"Carmo","lastName":"Gustavo P","documentHash":"2890e11a-0c7e-41cc-a155-3915611cfeec"},{"objectId":"67236c68fdbe8307b0e19d45","name":"Matkowski","lastName":"Rafał","documentHash":"551ddd81-0a23-452d-b909-8dc60a41424a"},{"objectId":"67236c68fdbe8307b0e19d44","name":"Szynglarewicz","lastName":"Bartłomiej","documentHash":"f4815df1-123b-4e15-8f89-21574832092f"},{"objectId":"67236c68fdbe8307b0e19d43","name":"Lis","lastName":"Michał","documentHash":"dbec7000-2ace-490c-9654-2586db45f46d"},{"objectId":"67236c68fdbe8307b0e19d42","name":"Kasprzak","lastName":"Piotr","documentHash":"93f0cac5-61c0-4257-9de7-d16aeedaebce"},{"objectId":"6541c63a40e3ff4ef3f304eb","name":"Adrianna","lastName":"Szumiejko","uuid":"17C40CCB5DD256BE78435143D4EACCCE9678692313E165D1373960CEFC50216AFA7951D4CD87908300BCFE3C380F1FFBA53110D711E9C7A74CADA38D5E3D2528","documentHash":"10d46161-4164-47ea-849f-d05f7dfc4481"},{"objectId":"6365d8b97523405a7dce8db7","name":"Artur","lastName":"Kwiatkowski","uuid":"5DA540116E22015E38D0D0C5182CB5EC10E28F831CCDC04695E4674EE1B7FB75BEB1626B868F465F63DD5C81081CD42F33039FB8D69CAB0E6E115EC71A569B0E","documentHash":"6b464c68-bcf9-4d67-8cbd-f6d759005f55"},{"objectId":"602ccbac9543c7410626e372","name":"Mateusz","lastName":"Dymek","uuid":"6D6FF4CF207C71AEC029BDA6D6A1AB42711985C66EBC473A96263FE7F3782076896D3F85EC1150042B1790A1F20BADF5E7B66A5E9B1F4C82F0A9B8073EF7BAAF","documentHash":"21208f42-897c-481a-8d01-cdb373ac452c"},{"objectId":"5e709459878c28a0473bb1c5","name":"Bartosz","lastName":"Dołęga-Kozierowski","uuid":"5729047AEC3177ACE97AB34DF58D908E43F299EF0D8F14464F6567D95DE56E65B08D0F1C1E8183FD64BAFC392CBD0534EC6CC480C9D6837B42AF534965D3D491","documentHash":"5d144a7f-1391-411b-9c9a-769226bfe6ec"},{"objectId":"5e7093bb878c28a0473afe98","name":"MARIUSZ","lastName":"PTAK","uuid":"BB3F1B2F6BE4685E7FE502429D4A8FBC54AA7C3D61D8BE89E0F622B155DFBC91D4F15D29F3278E6F53EB4D88E8150B27614931252E774EFB8E1CC821A53CD995","orcidId":"0000-0001-8081-8336","documentHash":"c7d273ee-fbab-4dd7-ad8b-0c17dd6d302c"},{"objectId":"5e709381878c28a0473ab7e8","name":"MAREK","lastName":"SAWICKI","uuid":"14E7184544DF2759E88BACA67480ED1CD03B88FA5058F1C3D9AB926988B92E59326DBBFFAFE3CA0B885DD9999D3F6B25352C5FB9658636BAAA3F64B06B51D72E","orcidId":"0000-0002-9649-8434","documentHash":"716b79af-ff24-409f-8631-aca0cd23678c"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDateMode":"AT_PUBLICATION","mode":"OTHER","releaseDateMonth":"JULY","releaseDateYear":2023},"objectId":"65967b8f4097074a39009682","doi":"10.1007/s10549-023-07056-1","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Numerical and physical modeling of breast cancer based on image fusion and artificial intelligence","otherTitles":[],"abstracts":[],"affiliations":[{"id":"5e70918b878c28a04737de34","uid":"bX41kHc85ivocrWE0ISfROw","uuid":"dbdda9a7-f6f7-44e8-af1d-9863e2256ca3","name":"Politechnika Wrocławska","affiliatedPersonIDs":["602ccbac9543c7410626e372","5e709381878c28a0473ab7e8","5e7093bb878c28a0473afe98","6541c63a40e3ff4ef3f304eb"],"parentId":"5e70918b878c28a04737de34","parentUuid":"dbdda9a7-f6f7-44e8-af1d-9863e2256ca3","rootId":"5e70918b878c28a04737de34","rootUuid":"dbdda9a7-f6f7-44e8-af1d-9863e2256ca3","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["5e709459878c28a0473bb1c5"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"vol. 202","pagesFromTo":"33-43","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["5e709459878c28a0473bb1c5","67236c68fdbe8307b0e19d42","67236c68fdbe8307b0e19d43","67236c68fdbe8307b0e19d44","67236c68fdbe8307b0e19d45","5e709381878c28a0473ab7e8","602ccbac9543c7410626e372","6541c63a40e3ff4ef3f304eb","67236c68fdbe8307b0e19d46","6365d8b97523405a7dce8db7","67236c68fdbe8307b0e19d47","5e7093bb878c28a0473afe98"]},"journal":{"objectId":"5e6f7d4a878c285145477443","mniswId":"2794","title":"Breast Cancer Research and Treatment","issn":"0167-6806","eissn":"1573-7217","metadataSource":"SCOPUS","documentHash":"acd7329f-d09a-4ce9-b71f-5efaffe01d8c"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747059258826"},{"authors":[{"objectId":"66f29807fdbe832f6801192a","name":"Damian","lastName":"Ślepecki","documentHash":"5d2cf1fb-6c3c-4359-bf9a-72221d0cf49a"},{"objectId":"5e709304878c28a0473a1383","name":"Aneta","lastName":"Kowal","uuid":"A8A3E9D8910B5144EE4F798C32AC268B77CBC631DA33653901A123334DF6898EA629E2F93FF4FD7FB5D1B32BB11F753E1DA965D32CEDAA05CEE3ED908C61F5D0","documentHash":"ab332d5d-4744-4452-a3e6-d670067c68bd"}],"objectId":"66f29807fdbe832f68011929","publicUri":"https://journals.viamedica.pl/onkologia_w_praktyce_klin_edu/article/view/96064","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Przypadek chorej z długotrwałą odpowiedzią na immunoterapię pembrolizumabem w pierwszej linii poddanej zabiegowi kardiochirurgicznemu powikłanemu COVID-19","otherTitles":[],"abstracts":[{"languageCode":"pol","content":"Chora w wieku 60 lat została skierowana do ośrodka autorów w celu diagnostyki i leczenia guza płuca prawego. Rozpoznano raka gruczołowego płuca w IV stadium zaawansowania, z wysoką ekspresją PD-L1. Pacjentka została zakwalifikowana do monoterapii pembrolizumabem w 2019 roku. W czasie leczenia przebyła pomyślnie zabieg kardiochirurgiczny wymiany zastawki aorty z powodu ciężkiej stenozy oraz zapalenie płuc w przebiegu COVID. Odpowiedź na leczenie przeciwnowotworowe była bardzo dobra (PR — częściowa odpowiedź wg RECIST 1.1) i utrzymuje się nadal. Dotąd chora otrzymała 63 cykle podania pembrolizumabu z dobrą tolerancją leczenia."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["5e709304878c28a0473a1383"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"pol","mainLanguageName":"polski","volume":"Tom 9, Supl. B (2023)","pagesFromTo":"12-21","articleEvaluation":{"indexedJournal":false,"isReview":true,"wosConference":false},"contributionOrder":{"AUTHOR":["5e709304878c28a0473a1383","66f29807fdbe832f6801192a"]},"journal":{"objectId":"5e6f7d52878c28514547a227","mniswId":"1001519","title":"Onkologia w Praktyce Klinicznej","issn":"1734-3542","eissn":"1734-6460","metadataSource":"IMPORT","documentHash":"a1c2c992-0a26-44e1-ae9f-a3e9e4469f78"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747059766187"},{"authors":[{"objectId":"66f2969afdbe832f68011064","name":"Damian","lastName":"Ślepeck","documentHash":"46043123-bf57-4e0b-a2cf-8485a726d01f"},{"objectId":"5e709304878c28a0473a1383","name":"Aneta","lastName":"Kowal","uuid":"A8A3E9D8910B5144EE4F798C32AC268B77CBC631DA33653901A123334DF6898EA629E2F93FF4FD7FB5D1B32BB11F753E1DA965D32CEDAA05CEE3ED908C61F5D0","documentHash":"ab332d5d-4744-4452-a3e6-d670067c68bd"}],"objectId":"66f2969afdbe832f68011063","publicUri":"https://journals.viamedica.pl/onkologia_w_praktyce_klin_edu/article/view/96064","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Przypadek chorej z długotrwałą odpowiedzią na immunoterapię pembrolizumabem w pierwszej linii poddanej zabiegowi kardiochirurgicznemu powikłanemu COVID-19","otherTitles":[],"abstracts":[{"languageCode":"pol","content":"Chora w wieku 60 lat została skierowana do ośrodka autorów w celu diagnostyki i leczenia guza płuca prawego. Rozpoznano raka gruczołowego płuca w IV stadium zaawansowania, z wysoką ekspresją PD-L1. Pacjentka została zakwalifikowana do monoterapii pembrolizumabem w 2019 roku. W czasie leczenia przebyła pomyślnie zabieg kardiochirurgiczny wymiany zastawki aorty z powodu ciężkiej stenozy oraz zapalenie płuc w przebiegu COVID. Odpowiedź na leczenie przeciwnowotworowe była bardzo dobra (PR — częściowa odpowiedź wg RECIST 1.1) i utrzymuje się nadal. Dotąd chora otrzymała 63 cykle podania pembrolizumabu z dobrą tolerancją leczenia."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["5e709304878c28a0473a1383"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"pol","mainLanguageName":"polski","volume":"9","issue":"suplement B","pagesFromTo":"12-21","articleEvaluation":{"indexedJournal":false,"isReview":true,"wosConference":false},"contributionOrder":{"AUTHOR":["5e709304878c28a0473a1383","66f2969afdbe832f68011064"]},"journal":{"objectId":"5e6f7d52878c28514547a227","mniswId":"1001519","title":"Onkologia w Praktyce Klinicznej","issn":"1734-3542","documentHash":"6c4587fb-53eb-4d4a-ab2e-596f864e1edf"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":false,"translationEditors":[],"keywords":[{"languageCode":"pol","keywords":["rak gruczołowy płuca niedrobnokomórkowy rak płuca leczenie pierwszej linii pembrolizumab wtórna niewydolność nadnerczy"]}],"lastRefresh":"1747059766704"},{"authors":[{"objectId":"6708e416fdbe833af652cea4","name":"Marlena","lastName":"Orlikowska","documentHash":"f6a27714-8f45-42f4-936a-3f1ec9e7568b"},{"objectId":"6708e416fdbe833af652cea3","name":"Danuta","lastName":"Mańka","documentHash":"79084d27-2c8e-4508-a267-fae47d130282"},{"objectId":"6708e416fdbe833af652cea2","name":"Beata","lastName":"Kania-Zembaczyńska","documentHash":"7c9be68f-a92d-4e07-9835-18a0e52ea784"},{"objectId":"6708e416fdbe833af652cea1","name":"Małgorzata","lastName":"Foszczyńska-Kłoda","documentHash":"d5975d0a-f317-4597-b7ef-ccf37a73f323"},{"objectId":"6708e416fdbe833af652cea0","name":"Katarzyna","lastName":"Hetman","documentHash":"bad84b0b-55c6-4000-a653-a2cfcadbf2ba"},{"objectId":"6708e416fdbe833af652ce9f","name":"Michalina","lastName":"Żurowska","documentHash":"178812b9-eb9a-472d-859a-48fdee6b3335"},{"objectId":"6708e416fdbe833af652ce9d","name":"Aleksandra","lastName":"Jackowska","documentHash":"a9f8ff6d-e404-45d4-86db-aee5748f850d"},{"objectId":"6708e416fdbe833af652ce9c","name":"Marek","lastName":"Gełej","documentHash":"d7205a6d-f1e2-41cb-b5f7-be0d5b1feb60"},{"objectId":"6708e416fdbe833af652ce9b","name":"Barbara","lastName":"Radecka","documentHash":"726aa75b-eb24-40be-8adb-09e5b57e1c22"},{"objectId":"61ea28b875234061bbd3c281","name":"Emilia","lastName":"Filipczyk-Cisarż","uuid":"5F0CC9CBBBE59951DC3EACEF09D88D0EF6B7E21F3F62DF0A15F5021EAF8A6893E894F2416B9A11DB606A638688EEC0DD235C55093F60B5AC42ACD5EC886366D8","documentHash":"8ed923f7-580d-4faa-898d-8fccc3167166"},{"objectId":"61ea28b875234061bbd3c227","name":"Mateusz","lastName":"Malik","uuid":"E10C5FF6B24F9CB3F38E63DAE9909766E2F3D709424B581C90C3872E6FBE84412764D5FC8754E23364225C5F44C9D53E3CFAC24320E755E9F2A13213197E48D6","documentHash":"5b20b002-b90f-4ba9-a4a6-f02935e0ea43"},{"objectId":"5e7093f5878c28a0473b404b","name":"Lubomir","lastName":"Bodnar","uuid":"E27FCD39928F7C05FFAD3029B8ED93BA48503D1C860E67CE938DB4FFE7C18285D321CC4D8CB0BF5A87D12D33ED1F6AEF201F69D2DE93FB34448F4B98D7484587","orcidId":"0000-0001-8548-8778","documentHash":"b8e08578-8def-4294-b4a8-f28c94bd98f0"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2024-09-11","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"6708e416fdbe833af652ce99","doi":"10.3390/biomedicines12092076","publicUri":"https://www.mdpi.com/2227-9059/12/9/2076","type":"ARTICLE","typeName":"Artykuł","year":2024,"title":"Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"In advanced-stage colorectal cancer (CRC), a strategy based on a sequence of systemic therapies brings survival benefits in most patients. Trifluridine and tipiracil hydrochloride (TT) is a chemotherapy drug effective in patients in the third- or later line setting. No highly specific biomarkers have been established for TT therapy so far. However, a systemic immune-inflammation index (SII), which is based on platelet, neutrophil and lymphocyte counts is applied to predict prognosis. In this retrospective, multicenter study, clinical data on 179 metastatic CRC patients treated with TT were collected. To evaluate factors predicting TT therapy response and overall survival, univariate logistic regression analysis was conducted. Subsequently, factors with p < 0.05 in univariate analysis were included in multivariate analysis. In the multivariate analysis of progression-free survival (PFS), three favorable parameters were significant: good to moderate histological differentiation (p = 0.0038), carcinoembryonic antigen (CEA) < 5 ng/L (p = 0.0316) and SII ≤ 550 (p = 0.007). Favorable prognostic factors revealed in the multivariate analysis of overall survival (OS) were: <3 prior lines of treatment (p = 0.02), good to moderate histological differentiation (p = 0.0003), CEA < 5 ng/L (p = 0.0227) and SII ≤ 550 (p = 0.0001). Our study indicated that pre-treatment SII may be clinically useful for selecting likely responder patients and assessing the prognosis for mCRC patients treated with TT."}],"affiliations":[{"id":"5e70918b878c28a04737de3b","uid":"bz_6XXECFL3_CFkpms5BsDQ","uuid":"dacccb40-e3e3-4113-a28e-54c4a59d550e","name":"Uniwersytet w Siedlcach","affiliatedPersonIDs":["5e7093f5878c28a0473b404b"],"parentId":"5e70918b878c28a04737de3b","parentUuid":"dacccb40-e3e3-4113-a28e-54c4a59d550e","rootId":"5e70918b878c28a04737de3b","rootUuid":"dacccb40-e3e3-4113-a28e-54c4a59d550e","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c281","61ea28b875234061bbd3c227"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"12","issue":"9","pagesFromTo":"2076","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["61ea28b875234061bbd3c227","6708e416fdbe833af652ce9b","6708e416fdbe833af652ce9c","6708e416fdbe833af652ce9d","61ea28b875234061bbd3c281","6708e416fdbe833af652ce9f","6708e416fdbe833af652cea0","6708e416fdbe833af652cea1","6708e416fdbe833af652cea2","6708e416fdbe833af652cea3","6708e416fdbe833af652cea4","5e7093f5878c28a0473b404b"]},"journal":{"objectId":"5e6f7d58878c28514547bb72","mniswId":"2502","title":"Biomedicines","issn":"2227-9059","eissn":"2227-9059","metadataSource":"WOS","documentHash":"0606c349-3dc9-452c-99fd-bb4e4300270c"},"_version":4,"journalIssue":{"objectId":"66d170effdbe8378e2acd9c3","year":"2024","volume":"12","number":"9","documentHash":"ddf860ac-de9b-4caa-abde-73de2b07d17b"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["Cancer","Systemic inflammation markers","Chemotherapy","mCRC","Prognosis"]}],"lastRefresh":"1747060002529"},{"authors":[{"objectId":"675ad787fdbe837850fa4504","name":"Barbara","lastName":"Radecka","documentHash":"71ea92cb-759f-4510-ba49-5c4bafa3b193"},{"objectId":"675ad787fdbe837850fa4503","name":"Piotr","lastName":"Wiosek","documentHash":"18747966-2935-4759-b335-87cf741793fb"},{"objectId":"675ad787fdbe837850fa4502","name":"Katarzyna","lastName":"Wierzbicka","documentHash":"b2ee110f-9232-4cf5-9cc6-6c536b5994b1"},{"objectId":"675ad787fdbe837850fa4501","name":"Joanna","lastName":"Streb","documentHash":"e88a0951-9f8f-4b57-8ba7-708ca4327b56"},{"objectId":"675ad787fdbe837850fa44ff","name":"Maciej","lastName":"Kawecki","documentHash":"5ffabc0f-37ec-4031-a013-597cb5ac05a7"},{"objectId":"675ad787fdbe837850fa44fe","name":"Katarzyna","lastName":"Hetman","documentHash":"6977bb96-20ee-4e07-bea1-667efded9c73"},{"objectId":"675ad787fdbe837850fa44fd","name":"Agnieszka","lastName":"Gwóźdź-Cieślik","documentHash":"9979f49f-b8c3-4b4a-b655-9c3a06c61b7b"},{"objectId":"675ad787fdbe837850fa44fc","name":"Łukasz","lastName":"Galus","documentHash":"33d79f0f-9557-4f65-917d-ee4c3a11be1e"},{"objectId":"675ad787fdbe837850fa44fb","name":"Bogumiła","lastName":"Galińska","documentHash":"a28795fe-9cbb-455f-8c0d-ad732aa1ed61"},{"objectId":"675ad787fdbe837850fa44fa","name":"Anna","lastName":"Dejws-Wątróbowska","documentHash":"06775e7b-c19e-4ffa-8ee9-d99f1685b551"},{"objectId":"675ad787fdbe837850fa44f9","name":"Maria","lastName":"Dąbrowska","documentHash":"559c9100-a672-42a6-b233-b2ac286b6de0"},{"objectId":"675ad787fdbe837850fa44f8","name":"Patryk","lastName":"Zając","documentHash":"c215eb8a-a8c1-4b16-a679-371a648dc8b3"},{"objectId":"61ea28b875234061bbd3c227","name":"Mateusz","lastName":"Malik","uuid":"E10C5FF6B24F9CB3F38E63DAE9909766E2F3D709424B581C90C3872E6FBE84412764D5FC8754E23364225C5F44C9D53E3CFAC24320E755E9F2A13213197E48D6","documentHash":"5b20b002-b90f-4ba9-a4a6-f02935e0ea43"},{"objectId":"614009299543c7051ff01c38","name":"Marek","lastName":"Gełej","uuid":"BAF473949891B0E0FBC6A06987D772304704DD5FD47795FF673BF5BD4004C7E73793546D18D1BB84AB172670DFACD9FC68C83B9567E1DC7899F40A03292780BB","documentHash":"cd36aa72-c855-4d39-b7c8-f988cf3547b2"}],"objectId":"675ad787fdbe837850fa44f6","doi":"10.5603/ocp.96898","publicUri":"https://journals.viamedica.pl/oncology_in_clinical_practice/article/viewFile/96898/74108","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"The BRAF mutation occurs in 8–12% of patients with colorectal cancer. This is associated with unfavorable prognosis — in metastatic disease, median survival does not exceed one year. Molecularly targeted treatment — encorafenib with cetuximab — is the standard of care in cases of chemotherapy failure."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c227"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","articleEvaluation":{"indexedJournal":false,"isReview":true,"wosConference":false},"contributionOrder":{"AUTHOR":["614009299543c7051ff01c38","675ad787fdbe837850fa44f8","675ad787fdbe837850fa44f9","675ad787fdbe837850fa44fa","675ad787fdbe837850fa44fb","675ad787fdbe837850fa44fc","675ad787fdbe837850fa44fd","675ad787fdbe837850fa44fe","675ad787fdbe837850fa44ff","61ea28b875234061bbd3c227","675ad787fdbe837850fa4501","675ad787fdbe837850fa4502","675ad787fdbe837850fa4503","675ad787fdbe837850fa4504"]},"journal":{"objectId":"5ebffdf8ad49b31ccece7147","title":"Oncology in Clinical Practice","doi":"","issn":" 2450-1654","eissn":"2450-6478","documentHash":"d4b1ee55-16bf-4be2-93f6-8b18996422cc"},"_version":4,"journalIssue":{"objectId":"6596a9d14097074a39052978","year":"2023","documentHash":"04eaf8db-153a-47e0-b060-274ff2aa8864"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747060034286"},{"authors":[{"objectId":"6751befbfdbe835717e8d094","name":"Ewelina","lastName":"Iwaneczko","documentHash":"9409e4fd-35e5-402c-92d4-2e51a7ad0d64"},{"objectId":"6751befbfdbe835717e8d093","name":"Ewelina","lastName":"Czykalko","documentHash":"4b4a5023-6a55-4243-9f0f-f93af96b2bcb"},{"objectId":"6751befbfdbe835717e8d092","name":"Łukasz","lastName":"Łaczmański","documentHash":"c5252fa0-8521-455f-a4af-1d727f8ddfc4"},{"objectId":"6751befbfdbe835717e8d091","name":"Mariola","lastName":"Abrahamowska","documentHash":"7e5d49b1-0577-43e0-bbe1-7381a73429d0"},{"objectId":"61ea28b875234061bbd3c24a","name":"Piotr","lastName":"Kasprzak","uuid":"FFCB5C65200F9E393424B158F00412ACD4DB0DE47657D4F98F03FFB9F899E5D7CFEDAE69CBB495848B6FA1E1D739C611B47595B306BCAC34D362A3CF28C9ACD6","documentHash":"e9143d79-56e8-429f-b043-43b1229a6313"},{"objectId":"5ebed566752340254fc40263","name":"Stanisław","lastName":"Supplitt","uuid":"E9E6F62CCE01137F2BF149C41BE285A796F9DEC143BA79A3E2FC14153C9B4D8ADE90FFF4E3447190946A0DBBA42E20DD383CB5AA69E93E5FD77A4CC9DDBE1D8A","orcidId":"0000-0002-5619-6087","documentHash":"0439d362-8546-46c3-a06f-0c94387e3393"},{"objectId":"5e7094c7878c28a0473c37fb","name":"Bartłomiej","lastName":"Szynglarewicz","uuid":"5DAAF83019AE2010BC98A6D1989198209BE5435FE5FCAD759DC83AAC559DE1A4918A57F63D40C9C4422464ED648479B0BD079099196A34C3D77C433922EF4647","orcidId":"0000-0002-1153-5647","documentHash":"58c6fb12-901d-49dd-ab3e-cce619384c0d"},{"objectId":"5e709433878c28a0473b7ff1","name":"Adam","lastName":"Maciejczyk","uuid":"4951FC5582B451CF799238B3FB3507897BB1EDCC864B23E491946D759689D1C0DE7AD290F819B8A1789355EBE6E120C746392BA55E14C7DDD1DDA53BB9150767","orcidId":"0000-0002-7047-0433","documentHash":"cef045e4-3574-43d6-8f3d-1baed9fedb48"},{"objectId":"5e70930d878c28a0473a1eb4","name":"Izabela","lastName":"Łaczmańska","uuid":"B05D123D2328E2638E89652E3A9FFE560F0BB38E3DD84F5FD0AD943B9327CC7BDF0117394CE9CB5713856ADB36478ADF09804484330B1ABBEE88B5B10D974CF6","orcidId":"0000-0003-2458-5755","documentHash":"cd97c558-05a6-4dde-b23d-61c4fcf16cab"},{"objectId":"5e70930a878c28a0473a1aa4","name":"Rafał","lastName":"Matkowski","uuid":"99B055AD582A83F9ACCB46B5F13634676074A0964285A2AB8B93FB85907E2BE1B0B0A5E9FA3897E4D6B6B080AC9718B512ADE08CC059FDDC75BB60C52873C7CE","orcidId":"0000-0002-1705-5097","documentHash":"fc9ac5b6-d872-46ba-b830-b2be4efcaf8d"},{"objectId":"5e709306878c28a0473a146f","name":"Maria","lastName":"Sąsiadek","uuid":"00D100F60C69EADF0046876E0ABB84FD2DC3EBE51289B7A43E530192DE2081A976B46CC39A19C672A6169FFEC36BDBDBFB98FB13EDA64216ACA650B6A2CEA2EA","orcidId":"0000-0002-7599-7074","documentHash":"b494df4c-4ef1-4786-9f7d-e37c9a6579ff"},{"objectId":"5e709305878c28a0473a143b","name":"PAWEŁ","lastName":"KARPIŃSKI","uuid":"9D39828500B02971A38628CD1AFC086742AA2253A8BF5015594D9F8B4F930FF404E4BBAF1798910F5C6821425540CF23FE70E08357E1D4AD626B1D68C1D42F01","orcidId":"0000-0003-3885-694X","documentHash":"53687b98-5467-408a-a2b0-24759c1b53f2"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2024-07-30","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"6751befbfdbe835717e8d090","doi":"10.1007/s10549-024-07441-4","publicUri":"https://link.springer.com/article/10.1007/s10549-024-07441-4","type":"ARTICLE","typeName":"Artykuł","year":2024,"title":"Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Introduction: Homologous recombination (HR) is a crucial DNA-repair mechanism, and its disruption can lead to the accumulation of mutations that initiate and promote cancer formation. The key HR genes, BRCA1 and BRCA2, are particularly significant as their germline pathogenic variants are associated with a hereditary predisposition to breast and/or ovarian cancer.\n\nMaterials and methods: The study was performed on 45 FFPE breast cancer tissues obtained from 24 and 21 patients, with and without the germline BRCA1/2 mutation, respectively. The expression of 11 genes: BRCA1, BRCA2, ATM, BARD1, FANCA, FANCB, FANCI, RAD50, RAD51D, BRIP1, and CHEK2 was assessed using Custom RT2 PCR Array (Qiagen), and results were analysed using R.\n\nResults: Cancer tissues from patients with BRCA1 or BRCA2 germline mutations displayed no significant differences in the expression of the selected HR genes compared to BRCA1 or BRCA2 wild-type cancer tissues. In BRCA1mut cancer tissues, BRCA1 expression was significantly higher than in BRCA2mut and BRCA wild-type cancer tissues.\n\nConclusions: In cancer tissues harbouring either BRCA1 or BRCA2 germline mutations, no significant differences in expression were observed at the mRNA level of any tested HR genes, except BRCA1. However, the significant differences observed in BRCA1 expression between germline BRCA1mut, germline BRCA2mut and BRCA1/2wt tissues may indicate a compensatory mechanism at the mRNA level to mitigate the loss of BRCA1 function in the cells."}],"affiliations":[{"id":"5e70918b878c28a04737de56","uid":"bHhhRrJPOI9BMfGA4x5cmvQ","uuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","name":"Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu","affiliatedPersonIDs":["5e70930a878c28a0473a1aa4","5e709306878c28a0473a146f","6751befbfdbe835717e8d091","5e7094c7878c28a0473c37fb","5ebed566752340254fc40263","5e70930d878c28a0473a1eb4","5e709305878c28a0473a143b","5e709433878c28a0473b7ff1"],"parentId":"5e70918b878c28a04737de56","parentUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","rootId":"5e70918b878c28a04737de56","rootUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c24a"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"208","issue":"3","pagesFromTo":"501-510","contributionOrder":{"AUTHOR":["5e70930d878c28a0473a1eb4","5e70930a878c28a0473a1aa4","5ebed566752340254fc40263","5e709305878c28a0473a143b","6751befbfdbe835717e8d091","6751befbfdbe835717e8d092","5e709433878c28a0473b7ff1","6751befbfdbe835717e8d093","6751befbfdbe835717e8d094","61ea28b875234061bbd3c24a","5e7094c7878c28a0473c37fb","5e709306878c28a0473a146f"]},"journal":{"objectId":"5e6f7d4a878c285145477443","mniswId":"2794","title":"Breast Cancer Research and Treatment","issn":"0167-6806","eissn":"1573-7217","metadataSource":"SCOPUS","documentHash":"acd7329f-d09a-4ce9-b71f-5efaffe01d8c"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["BRCA1/2 deficiency","Real-time PCR","Homologous recombination (HR)","Breast cancer"]}],"lastRefresh":"1747060091953"},{"authors":[{"objectId":"67599435fdbe83757db69d5a","name":"P.","lastName":"Rutkowski","documentHash":"f2fcc325-9f64-4536-bf25-a5d91749a7c8"},{"objectId":"67599435fdbe83757db69d59","name":"J.","lastName":"Mackiewicz","documentHash":"e2392435-3ec2-4d4a-831c-834d2108965c"},{"objectId":"67599435fdbe83757db69d58","name":"R.","lastName":"Suwinski","documentHash":"0de5efd4-876a-41ea-a838-2353b81f4b13"},{"objectId":"67599435fdbe83757db69d57","name":"G.","lastName":"Kamińska-Winciorek","documentHash":"cb30a0e4-84fe-4a4c-89ba-78b264fae087"},{"objectId":"67599435fdbe83757db69d56","name":"P.","lastName":"Rogala","documentHash":"ce9a1173-1e3d-4deb-beb2-902c1c68d16b"},{"objectId":"67599435fdbe83757db69d55","name":"E.","lastName":"Rutkowska","documentHash":"afde0f9c-9118-47c1-9aaa-7a73505b171b"},{"objectId":"67599435fdbe83757db69d53","name":"T.","lastName":"Switaj","documentHash":"f0c61b31-d66f-484a-af27-62ec0be5fbb6"},{"objectId":"67599435fdbe83757db69d52","name":"T.","lastName":"Kubiatowski","documentHash":"a2a42b30-d742-4a08-8b68-d609bb579e20"},{"objectId":"67599435fdbe83757db69d51","name":"W.","lastName":"Bal","documentHash":"26c1de6e-5a52-48ad-ad95-a357c77a1cae"},{"objectId":"67599435fdbe83757db69d50","name":"A.","lastName":"Kamycka","documentHash":"c5b3dcff-a1a6-403c-bfd8-8f676067a8c3"},{"objectId":"67599435fdbe83757db69d4f","name":"J.","lastName":"Seredynska","documentHash":"1b2fa4ea-87b3-4fb1-94e2-b769747cf34e"},{"objectId":"67599435fdbe83757db69d4e","name":"B.E.","lastName":"Ziolkowska","documentHash":"53434d19-c9aa-496a-bc1c-3977d62c04ff"},{"objectId":"67599435fdbe83757db69d4d","name":"L.","lastName":"Galus","documentHash":"17c17bac-7c1c-45fd-9639-f54a2fb85c33"},{"objectId":"67599435fdbe83757db69d4c","name":"R.","lastName":"Dziura","documentHash":"8fff0151-4bbd-48b2-9ab0-80ed726082cd"},{"objectId":"67599435fdbe83757db69d4b","name":"M.","lastName":"Ziętek","documentHash":"7bce23c3-a5c3-4c1f-923c-a2e3c3207f66"},{"objectId":"67599435fdbe83757db69d4a","name":"K.","lastName":"Piejko","documentHash":"21694bef-003f-4331-91fb-eba499cb138e"},{"objectId":"67599435fdbe83757db69d49","name":"K.","lastName":"Ostaszewski","documentHash":"072e1f38-7539-445d-aa4f-b265572ae9f8"},{"objectId":"67599435fdbe83757db69d48","name":"A.M.","lastName":"Czarnecka","documentHash":"8bc6d6f1-c0da-4f71-8636-1af707e2b4a2"},{"objectId":"67599435fdbe83757db69d47","name":"B.","lastName":"Cybulska-Stopa","documentHash":"709fcb5b-2884-4c81-a5ff-2eec34b9eaa1"},{"objectId":"61ea28b875234061bbd3c29b","name":"Natasza","lastName":"Kempa-Kamińska","uuid":"6E3454023C2C2F3D25688B923C8B056B97F4DFE25D4F4AFAC17ABB328F88D647843891BC939AD61FB738060BB7FA73279D0A0EB707FBB179CB03D976F6B48AD1","documentHash":"0027317f-2101-46a7-8721-38d17fe4a474"}],"objectId":"67599435fdbe83757db69d45","doi":"10.1016/j.annonc.2022.07.961","publicUri":"https://api.elsevier.com/content/article/PII:S0923753422028125?httpAccept=text/xml","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"835P Efficacy of checkpoint inhibitors and targeted therapy depending on the line of treatment in patients with advanced / metastatic melanoma","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"The use of targeted therapies (TT) and checkpoint inhibitors (IT) in patients with melanoma significantly prolonged survival, especially in the group of patients with BRAF-mutated melanoma. The aim of this study was to evaluate real-life outcomes of advanced melanoma second line therapy in TT-IT and IT-TT sequence with BRAFi/MEKi combination or anti-PD1 agent."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c29b"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"33","pagesFromTo":"S930-S931","articleEvaluation":{"indexedJournal":false,"isReview":true,"wosConference":false},"contributionOrder":{"AUTHOR":["67599435fdbe83757db69d47","67599435fdbe83757db69d48","67599435fdbe83757db69d49","67599435fdbe83757db69d4a","67599435fdbe83757db69d4b","67599435fdbe83757db69d4c","67599435fdbe83757db69d4d","67599435fdbe83757db69d4e","67599435fdbe83757db69d4f","67599435fdbe83757db69d50","67599435fdbe83757db69d51","67599435fdbe83757db69d52","67599435fdbe83757db69d53","61ea28b875234061bbd3c29b","67599435fdbe83757db69d55","67599435fdbe83757db69d56","67599435fdbe83757db69d57","67599435fdbe83757db69d58","67599435fdbe83757db69d59","67599435fdbe83757db69d5a"]},"journal":{"objectId":"5e6f7d4a878c28514547708b","mniswId":"1273","title":"ANNALS OF ONCOLOGY","issn":"0923-7534","eissn":"1569-8041","documentHash":"73b6a302-aa5e-4b39-bbca-a1ec805c6244"},"_version":4,"journalIssue":{"objectId":"67599435fdbe83757db69d46","year":"2022","volume":"33","documentHash":"6357e76d-f1d8-4617-9dcc-94ae006822ff"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747060101503"},{"authors":[{"objectId":"6630be394097076263e73d91","name":"Wioletta","lastName":"Dziubek","documentHash":"674ead56-3731-49b5-b67c-3834d0b20d5e"},{"objectId":"6630be394097076263e73d90","name":"Claire","lastName":"Gerall","documentHash":"4a536bf5-ef64-4bc1-8089-d00bf62611db"},{"objectId":"6630be394097076263e73d8f","name":"Małgorzata","lastName":"Stefańska","documentHash":"caa353a2-28b1-47db-bdba-9d707b18fcc4"},{"objectId":"6630be394097076263e73d8e","name":"Joanna","lastName":"Kowalska","documentHash":"404499e0-db18-4995-aa4b-689d80befb85"},{"objectId":"61eb7a3875234061bbd4447f","name":"Weronika","lastName":"Pawlaczyk","uuid":"69CD6AE848C62CEE7A944898CF37AB4945D20EF408A931CF14BA136674A2E01505DD56FCC992CB7D2447C56A1432273180D4B0591FA85507DCC3B4541E3827E3","documentHash":"76c5bc68-2128-46de-9d9a-1120f9bbfeef"},{"objectId":"5e7093d0878c28a0473b1330","name":"Łukasz","lastName":"Rogowski","uuid":"0776F294E47D3357A4EAB05DB59C414997BBD6065070F2B6AC091F97CE65D45BBF17B346CA4E462C4A2D6E74C19012090CA7C1EE2AA2D5EF740D41E455EB9412","documentHash":"ffc3f430-55f7-4abd-bd9c-17e9c9a18a96"},{"objectId":"5e7093b5878c28a0473af754","name":"Tomasz","lastName":"Gołębiowski","uuid":"CB5DED134C28CA2E746394D64B3F8F7892A36B583817C9116510BD71915BECF3855BDDCBB50B6ADBC5D9D6DDF327A7964372357CE153FE22BF53CE719D178D95","orcidId":"0000-0001-5477-2020","documentHash":"595d2d34-3d7b-4037-aa45-a0219cd2e42c"},{"objectId":"5e70930d878c28a0473a1ef3","name":"Mariusz","lastName":"Kusztal","uuid":"F4D7CF65E6FE7C78DABCAFDA4CF34C5955A0703F8D921724C6AA2E063480F8721B303C833A6DBA8C6872FD733C3D83F249DD22FB3E8DB2BE0093487F9CCC8047","orcidId":"0000-0002-6502-0374","documentHash":"c96caacf-6cda-4a71-aea9-768bed2c85e6"},{"objectId":"5e709304878c28a0473a1354","name":"MAGDALENA","lastName":"KRAJEWSKA","uuid":"24BD21FEF2D2C8CA3880ADF08AA3B3D165FA3F8DE2FB61B86CDB2AA8DF8817AE7760984796CF9BA0161C5D4A7C13EE580B1DBF8BEBD37D39EBB784E641B3B2A5","orcidId":"0000-0002-2632-2409","documentHash":"e1b1f8a7-2031-4d99-bdb6-37a8d0b08d51"},{"objectId":"5e709304878c28a0473a1292","name":"Oktawia","lastName":"Mazanowska","uuid":"8016B6E5A8A5D864A39DF2031F80F7FD2E65211842B374E39E75642D04EA3A882FFFF9A3D5716E8EA52A08341992C17B821C01885DC5B5BD63D41ECDC3A481B8","orcidId":"0000-0001-7669-7543","documentHash":"2a03e8b1-14e7-413c-b6bf-0d18650c2502"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2022-11-14","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"6375f88440970765d462fd73","doi":"10.3390/nu14224814","publicUri":"https://www.mdpi.com/2072-6643/14/22/4814","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"Assessment of the nutritional status and quality of life in chronic kidney disease and kidney transplant patients: a comparative analysis","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Background: Chronic kidney disease (CKD) can significantly influence a patient’s nutritional status, leading to malnutrition. Malnutrition is associated with an increase in morbidity and hospital admissions, as well as a decrease in functional status. All these factors impact emotional, physical, and psychosocial health, leading to a lower quality of life (QOL). The aim of the study was to assess the nutritional status and QOL in patients with CKD compared to patients after kidney transplantation and determine what factors influence nutritional status and QOL in this patient population. Methods: The study included 167 patients: 39 pre-dialysis patients—group 1; 65 dialysis patients—group 2; 63 kidney transplant patients—group 3. Patients completed the Kidney Disease Quality of Life questionnaire (KDQoL) and the Mini Nutritional Assessment questionnaire (MNA). Results: A comparative analysis of the QOL of patients in the three study groups showed no statistically significant differences in the overall KDQoL scores. Factors that affected quality of life included the designated group, determined by disease status, MNA score, patient age, and WHR. Nearly 1/3 of patients from groups 2 and 3 were at risk of malnutrition. Conclusions: A systematic assessment of nutritional status and monitoring of QOL should be integrated into the standard management guidelines for CKD patients."}],"affiliations":[{"id":"5e70918b878c28a04737de56","uid":"bHhhRrJPOI9BMfGA4x5cmvQ","uuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","name":"Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu","affiliatedPersonIDs":["5e709304878c28a0473a1354","5e709304878c28a0473a1292","5e7093b5878c28a0473af754","5e70930d878c28a0473a1ef3"],"parentId":"5e70918b878c28a04737de56","parentUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","rootId":"5e70918b878c28a04737de56","rootUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","type":"AUTHOR"},{"id":"5e70918b878c28a04737de73","uid":"bK_32dO_H6Xbz9BQRyuOsfw","uuid":"01188a2d-6822-402e-9053-21ba791fac0b","name":"Collegium Witelona Uczelnia Państwowa","affiliatedPersonIDs":["5e7093d0878c28a0473b1330"],"parentId":"5e70918b878c28a04737de73","parentUuid":"01188a2d-6822-402e-9053-21ba791fac0b","rootId":"5e70918b878c28a04737de73","rootUuid":"01188a2d-6822-402e-9053-21ba791fac0b","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61eb7a3875234061bbd4447f"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"14","issue":"22","pagesFromTo":"art.4814 [11 s.]","contributionOrder":{"AUTHOR":["5e7093b5878c28a0473af754","5e709304878c28a0473a1292","5e709304878c28a0473a1354","5e70930d878c28a0473a1ef3","61eb7a3875234061bbd4447f","6630be394097076263e73d8e","6630be394097076263e73d8f","6630be394097076263e73d90","6630be394097076263e73d91","5e7093d0878c28a0473b1330"]},"journal":{"objectId":"5e6f7d4e878c2851454790a2","mniswId":"15295","title":"Nutrients","issn":"2072-6643","metadataSource":"IMPORT","documentHash":"249ff7e0-f443-46aa-b5c4-21f8cf400d2e"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["hemodialysis","kidney transplant","MNA","malnutrition","quality of life","KDQoL"]}],"lastRefresh":"1747060154197"},{"authors":[{"objectId":"678648d6fdbe831a381daf3d","name":"et","lastName":"al.","documentHash":"dec39ef7-8b41-462a-869b-3485c58041b9"},{"objectId":"674cdf99fdbe8357170ff425","name":"Piotr J.","lastName":"Wysocki","documentHash":"1b8cdc1f-b017-4224-a5e7-1a0dfcee4c6a"},{"objectId":"674cdf99fdbe8357170ff424","name":"Jolanta","lastName":"Dobrzańska","documentHash":"4414f36d-4a6f-4f21-a13e-3ab6736a3b59"},{"objectId":"674cdf99fdbe8357170ff423","name":"Łukasz","lastName":"Kwinta","documentHash":"8452fefe-140f-4987-9251-46c3a11c23c3"},{"objectId":"674cdf99fdbe8357170ff422","name":"Kamil","lastName":"Konopka","documentHash":"51e94ea4-a3e2-43da-96d7-4549b75fa83b"},{"objectId":"674cdf99fdbe8357170ff421","name":"Ewa","lastName":"Klank-Sokołowska","documentHash":"3338bbb3-1053-44f3-9263-e0d3fd3bd2fa"},{"objectId":"674cdf99fdbe8357170ff420","name":"Maria","lastName":"Dąbrowska","documentHash":"5d927fb0-d544-41dc-8f5e-1d793f6b261a"},{"objectId":"674cdf99fdbe8357170ff41f","name":"Justyna","lastName":"Czech","documentHash":"e4bd216a-4260-49b9-b0ea-b3b874ada66f"},{"objectId":"674cdf99fdbe8357170ff41e","name":"Robert","lastName":"Dziura","documentHash":"2d982f5a-b385-4f1c-81c7-85cc3f5a7ddf"},{"objectId":"674cdf99fdbe8357170ff41d","name":"Marek","lastName":"Szwiec","documentHash":"9d769576-5933-4e48-9c6c-78bb8fff9210"},{"objectId":"674cdf99fdbe8357170ff41c","name":"Anna","lastName":"Drosik-Kwaśniewska","documentHash":"523b3277-fc8c-47b1-9800-9828cc1204e3"},{"objectId":"674cdf99fdbe8357170ff41b","name":"Piotr","lastName":"Kolenda","documentHash":"3d3a85e3-eaf4-46be-be42-5a6585ee1e03"},{"objectId":"674cdf99fdbe8357170ff41a","name":"Krzysztof","lastName":"Adamowicz","documentHash":"1981548e-1305-44cf-9da7-ea12ead2144b"},{"objectId":"674cdf99fdbe8357170ff419","name":"Natalia","lastName":"Łaszewska-Kraińska","documentHash":"6538d15b-3c43-402c-91b4-3617d2825caf"},{"objectId":"674cdf99fdbe8357170ff418","name":"Natalia","lastName":"Jonak-Olczyk","documentHash":"dd80222a-5dba-494e-8592-e3ad69c6e6be"},{"objectId":"674cdf99fdbe8357170ff417","name":"Aneta","lastName":"Lebiedzińska","documentHash":"39b72f1c-3f5c-4bec-89b1-b8fa525ca979"},{"objectId":"674cdf99fdbe8357170ff416","name":"Grzegorz","lastName":"Słomian","documentHash":"9015068c-6bc4-4b86-ba4e-1c3297fda12c"},{"objectId":"674cdf99fdbe8357170ff415","name":"Magdalena","lastName":"Michalik","documentHash":"c4cc66c3-23d3-4a9d-8d32-9ecf56c8f08e"},{"objectId":"674cdf99fdbe8357170ff414","name":"Danuta","lastName":"Starzyczny-Słota","documentHash":"8fbea04a-5888-48c3-a6cd-3cfd3b383a0f"},{"objectId":"674cdf99fdbe8357170ff413","name":"Marcin","lastName":"Szweda","documentHash":"06ff828d-28b0-4650-b1bc-43ee0cfb4ef5"},{"objectId":"674cdf99fdbe8357170ff412","name":"Marzenna","lastName":"Samborska-Plewicka","documentHash":"ff808d0a-d3cb-423b-ae3d-027e4ef97e47"},{"objectId":"674cdf99fdbe8357170ff411","name":"Magdalena","lastName":"Kustra","documentHash":"a3026c23-2060-43cb-bf4f-686aace48583"},{"objectId":"674cdf99fdbe8357170ff410","name":"Maciej","lastName":"Kozaczka","documentHash":"36d82f17-811c-457f-852b-859ae1f67811"},{"objectId":"674cdf99fdbe8357170ff40e","name":"Dominik","lastName":"Haus","documentHash":"8810f2e0-9aaa-4384-9af0-7d1ae630959d"},{"objectId":"674cdf99fdbe8357170ff40d","name":"Rafał","lastName":"Wiśniowski","documentHash":"28e3a171-1b51-4e09-a72e-513bff008cbb"},{"objectId":"674cdf99fdbe8357170ff40c","name":"Paweł Michał","lastName":"Potocki","documentHash":"8d1c4aa4-ef36-40c0-aaa9-48a3bbd91e59"},{"objectId":"61ea28b875234061bbd3c236","name":"Zbyszko","lastName":"Chowaniec","uuid":"54CC591F8C269EC4C57FC517848C3ABCF0564604C8025367083DE16B8EA54235FDC0526AFDA0CE64BCEFEC27374B88B0DA18311D9373455356958EC108176523","documentHash":"d5b87a0d-df08-4ad4-8a94-251085c4a374"},{"objectId":"5e7094bc878c28a0473c2c86","name":"Marek","lastName":"Szwiec","uuid":"3BF662DE77C5DF5D5055F9B0F99551BADC24FAB9619B7FECE31B2495BC431666D393317F78D7EA8FB18BEC9224B9715CF8B26FDF41FED5A807BF6A97389922B6","documentHash":"99800eab-42b0-429f-ab74-22d98a1eb9ba"},{"objectId":"5e709319878c28a0473a2d49","name":"Ewa","lastName":"Nowakowska-Zajdel","uuid":"6548D93119B49D9E6C22D63F5C4ACFAF975956F6595B178D6F7FD4800B0ECF8A465E71D8A5C8B56CAC6BCBAE6CB3904AF58DBE8DB6C1B0975ACB7B183413EE71","orcidId":"0000-0003-3941-7308","documentHash":"af56752a-a18c-44ba-a522-706f65e73ebf"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2023-09-01","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"650d63a8409707142eeaf991","doi":"10.3390/cancers15174361","publicUri":"http://dx.doi.org/10.3390/cancers15174361","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"The Impact of Sidedness on the Efficacy of Anti-EGFR-Based First-Line Chemotherapy in Advanced Colorectal Cancer Patients in Real-Life Setting-A Nation-Wide Retrospective Analysis (RACER)","otherTitles":[],"abstracts":[],"affiliations":[{"id":"5e70918a878c28a04737de24","uid":"bk8UqEe0F8JQF-eB0VLAY0w","uuid":"41ade527-eee8-4133-87f6-f9acbecc3acf","name":"Uniwersytet Zielonogórski","affiliatedPersonIDs":["5e7094bc878c28a0473c2c86"],"parentId":"5e70918a878c28a04737de24","parentUuid":"41ade527-eee8-4133-87f6-f9acbecc3acf","rootId":"5e70918a878c28a04737de24","rootUuid":"41ade527-eee8-4133-87f6-f9acbecc3acf","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c236"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"},{"id":"5e70918b878c28a04737decc","uid":"b-COLbcdAG-k5w4OvZzdVBg","uuid":"bdcdbaed-bbf2-43bd-b224-c5d80dd351fb","name":"Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy","affiliatedPersonIDs":["674cdf99fdbe8357170ff41c"],"parentId":"5e70918b878c28a04737decc","parentUuid":"bdcdbaed-bbf2-43bd-b224-c5d80dd351fb","rootId":"5e70918b878c28a04737decc","rootUuid":"bdcdbaed-bbf2-43bd-b224-c5d80dd351fb","type":"AUTHOR"},{"id":"5e70918b878c28a04737de50","uid":"byQikIwqf13QiA2ApyMoNIQ","uuid":"cd474cbb-d4ba-4475-b0d0-580f5f2e17ef","name":"Śląski Uniwersytet Medyczny w Katowicach","affiliatedPersonIDs":["5e709319878c28a0473a2d49"],"parentId":"5e70918b878c28a04737de50","parentUuid":"cd474cbb-d4ba-4475-b0d0-580f5f2e17ef","rootId":"5e70918b878c28a04737de50","rootUuid":"cd474cbb-d4ba-4475-b0d0-580f5f2e17ef","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"Vol. 15","issue":"17","pagesFromTo":"1--17","articleEvaluation":{"isReview":false},"contributionOrder":{"AUTHOR":["674cdf99fdbe8357170ff40c","674cdf99fdbe8357170ff40d","674cdf99fdbe8357170ff40e","61ea28b875234061bbd3c236","674cdf99fdbe8357170ff410","674cdf99fdbe8357170ff411","674cdf99fdbe8357170ff412","674cdf99fdbe8357170ff413","674cdf99fdbe8357170ff414","674cdf99fdbe8357170ff415","674cdf99fdbe8357170ff416","674cdf99fdbe8357170ff417","674cdf99fdbe8357170ff418","674cdf99fdbe8357170ff419","674cdf99fdbe8357170ff41a","674cdf99fdbe8357170ff41b","674cdf99fdbe8357170ff41c","674cdf99fdbe8357170ff41d","674cdf99fdbe8357170ff41e","674cdf99fdbe8357170ff41f","674cdf99fdbe8357170ff420","5e709319878c28a0473a2d49","674cdf99fdbe8357170ff421","674cdf99fdbe8357170ff422","674cdf99fdbe8357170ff423","674cdf99fdbe8357170ff424","674cdf99fdbe8357170ff425","678648d6fdbe831a381daf3d","5e7094bc878c28a0473c2c86"]},"journal":{"objectId":"5e6f7d58878c28514547bc61","mniswId":"3233","title":"Cancers","issn":"2072-6694","metadataSource":"WOS","documentHash":"9418a906-5b75-4db1-84e3-dff82b7dd6bc"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[{"languageCode":"eng","keywords":["real-world","sidedness","colorectal cancer","Poland","anti-EGFR therapy","cetuximab","FOLFOX","panitumumab","chemotherapy","FOLFIRI"]}],"lastRefresh":"1747060321927"},{"authors":[{"objectId":"6630fec34097076263e92945","name":"Dominika","lastName":"Jaguś","documentHash":"70c55969-cbc6-41d7-b7b5-6a61ad68acb7"},{"objectId":"6630fec34097076263e92944","name":"Agnieszka","lastName":"Domalik","documentHash":"7f13dcb1-ec41-420a-b25f-60e8d7acf74c"},{"objectId":"6630fec34097076263e92943","name":"Anna","lastName":"Ćwierz-Pieńkowska","documentHash":"a1f36c1e-bbf8-4426-bd75-116713c8940f"},{"objectId":"6630fec34097076263e92942","name":"Anna","lastName":"Pawłowska","documentHash":"b9bb70d9-993a-435f-ad32-85e710a79bff"},{"objectId":"61ea28b875234061bbd3c24a","name":"Piotr","lastName":"Kasprzak","uuid":"FFCB5C65200F9E393424B158F00412ACD4DB0DE47657D4F98F03FFB9F899E5D7CFEDAE69CBB495848B6FA1E1D739C611B47595B306BCAC34D362A3CF28C9ACD6","documentHash":"e9143d79-56e8-429f-b043-43b1229a6313"},{"objectId":"61415aa99543c7051ff01c73","name":"Łukasz","lastName":"Fura","uuid":"E260A65283815595F962A5F5182AD04575AD4DA899D33ED6F6D3A5288205D8A9F04B9166EB40ADC71D31083B3B3505968A28FCF9793C0F0F78D251741DEA3903","orcidId":"0000-0003-4970-7261","documentHash":"0eb619e1-5206-4010-92d4-aee2a879f0ec"},{"objectId":"5e70930a878c28a0473a1aa4","name":"Rafał","lastName":"Matkowski","uuid":"99B055AD582A83F9ACCB46B5F13634676074A0964285A2AB8B93FB85907E2BE1B0B0A5E9FA3897E4D6B6B080AC9718B512ADE08CC059FDDC75BB60C52873C7CE","orcidId":"0000-0002-1705-5097","documentHash":"fc9ac5b6-d872-46ba-b830-b2be4efcaf8d"},{"objectId":"5e709287878c28a0473974de","name":"Norbert","lastName":"Żołek","uuid":"232227F62AEB88A1192DA4721A4140CEE8B3F6222F4BB042364C7B0837851E4305355974071F41E2F35FF50BCD51C30C3DE1F6487D0AE6F06E1263219F6B2403","documentHash":"2c1643e4-3524-4eb4-82bc-b982ec5df214"},{"objectId":"5e70927e878c28a047396b32","name":"Andrzej","lastName":"Nowicki","uuid":"E75D4D4C851DA12DEFC69404819DF0F313B8DA1C205183F9FDE24222D1E4027C5D6F463E8DC56E70C2C82425992E9D64D102442BDA73FFEC24D9FB304EC4966C","orcidId":"0000-0002-9260-8237","documentHash":"e2d916f0-a88c-4202-affc-f3afdef4cec7"}],"openAccess":{"textVersion":"FINAL_PUBLISHED","license":"CC_BY","releaseDate":"2024-01-31","releaseDateMode":"AT_PUBLICATION","mode":"OPEN_JOURNAL"},"objectId":"6601a9194097070f89f021d3","doi":"10.1038/s41597-024-02984-z","publicUri":"https://www.nature.com/articles/s41597-024-02984-z","type":"ARTICLE","typeName":"Artykuł","year":2024,"title":"Curated benchmark dataset for ultrasound based breast lesion analysis","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"A new detailed dataset of breast ultrasound scans (BrEaST) containing images of benign and malignant lesions as well as normal tissue examples, is presented. The dataset consists of 256 breast scans collected from 256 patients. Each scan was manually annotated and labeled by a radiologist experienced in breast ultrasound examination. In particular, each tumor was identified in the image using a freehand annotation and labeled according to BIRADS features and lexicon. The histopathological classification of the tumor was also provided for patients who underwent a biopsy. The BrEaST dataset is the first breast ultrasound dataset containing patient-level labels, image-level annotations, and tumor-level labels with all cases confirmed by follow-up care or core needle biopsy result. To enable research into breast disease detection, tumor segmentation and classification, the BrEaST dataset is made publicly available with the CC-BY 4.0 license."}],"affiliations":[{"id":"5e70918b878c28a04737de56","uid":"bHhhRrJPOI9BMfGA4x5cmvQ","uuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","name":"Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu","affiliatedPersonIDs":["5e70930a878c28a0473a1aa4"],"parentId":"5e70918b878c28a04737de56","parentUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","rootId":"5e70918b878c28a04737de56","rootUuid":"18711a61-b8cc-4cb5-97c3-893045eff81e","type":"AUTHOR"},{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c24a"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"11","pagesFromTo":"art.105000 [8 s.]","contributionOrder":{"AUTHOR":["6630fec34097076263e92942","6630fec34097076263e92943","6630fec34097076263e92944","6630fec34097076263e92945","61ea28b875234061bbd3c24a","5e70930a878c28a0473a1aa4","61415aa99543c7051ff01c73","5e70927e878c28a047396b32","5e709287878c28a0473974de"]},"journal":{"objectId":"5e6f7d5c878c28514547d2c1","mniswId":"18267","title":"Scientific data","eissn":"2052-4463","metadataSource":"SCOPUS","documentHash":"3d2b592d-a9e1-4710-b453-e73e0b3fea15"},"_version":4,"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747060777960"},{"authors":[{"objectId":"63d64abf40970753829313dd","name":"Piotr","lastName":"Rutkowski","documentHash":"7d8cf72a-8dca-4336-b639-909f732be622"},{"objectId":"63d64abf40970753829313dc","name":"Jacek","lastName":"Mackiewicz","documentHash":"64f009ac-3cb3-4ebb-8103-47fab311e914"},{"objectId":"63d64abf40970753829313db","name":"Rafał","lastName":"Suwiński","documentHash":"bc1b3a58-238f-4d55-8e75-2d0413175993"},{"objectId":"63d64abf40970753829313da","name":"Grazyna","lastName":"Kaminska-Winciorek","documentHash":"9fd03703-6e3f-4420-9036-58f34ffee4eb"},{"objectId":"63d64abf40970753829313d9","name":"Tomasz","lastName":"Switaj","documentHash":"b7cda4c4-5457-4c4e-a556-36ddd62f112e"},{"objectId":"63d64abf40970753829313d8","name":"Pawel","lastName":"Rogala","documentHash":"6914af8b-27da-414a-a22e-e378b7a33e5a"},{"objectId":"63d64abf40970753829313d7","name":"Tomasz","lastName":"Kubiatowski","documentHash":"d886a0d6-88bd-4641-81f9-dbe9df3defcf"},{"objectId":"63d64abf40970753829313d6","name":"Wieslaw","lastName":"Bal","documentHash":"9b7a21a7-bc71-4ffb-8603-f272444bf53e"},{"objectId":"63d64abf40970753829313d5","name":"Agnieszka","lastName":"Kamycka","documentHash":"e0f5abf5-5e4f-4412-9148-ce6c3cdfb4fa"},{"objectId":"63d64abf40970753829313d4","name":"Tomasz","lastName":"Zemelka","documentHash":"e50dcb19-5c0d-4409-ad5d-73b6966df5cd"},{"objectId":"63d64abf40970753829313d3","name":"Agata","lastName":"Sałek-Zań","documentHash":"0680bbb2-eeea-4d57-be2a-89b1f8da5c7b"},{"objectId":"63d64abf40970753829313d1","name":"Łukasz","lastName":"Galus","documentHash":"ea58ff91-deee-492a-9c53-2c1c4028b925"},{"objectId":"63d64abf40970753829313d0","name":"Ewa","lastName":"Rutkowska","documentHash":"53318724-be76-4720-819c-15211e8c646f"},{"objectId":"63d64abf40970753829313cf","name":"Robert","lastName":"Dziura","documentHash":"38ecb5d4-baa3-4c90-b3a9-1e7d5acab36e"},{"objectId":"63d64abf40970753829313ce","name":"Marcin","lastName":"Zietek","documentHash":"0be8c136-0001-4cc2-8de4-b76b32da54d8"},{"objectId":"63d64abf40970753829313cd","name":"Karolina","lastName":"Piejko","documentHash":"c481e0a9-db1f-49e1-8f9f-ce03b8d623bf"},{"objectId":"63d64abf40970753829313cc","name":"Krzysztof","lastName":"Ostaszewski","documentHash":"824cbe17-3d82-430c-b4f5-e9f889068b57"},{"objectId":"63d64abf40970753829313cb","name":"Anna Malgorzata","lastName":"Czarnecka","documentHash":"9a419f13-f25e-42a7-9e8c-b5f02c7f9668"},{"objectId":"63d64abf40970753829313ca","name":"Bozena","lastName":"Cybulska-Stopa","documentHash":"1ea09590-dde1-45cd-8d3a-6edbaba84211"},{"objectId":"61ea28b875234061bbd3c28b","name":"Jacek","lastName":"Calik","uuid":"42057AF4F0B4C08143DCC8A9C8E624C619B3AFBBEE872E678303FDEF817BCE650C688597930745067FD75710A6FD1D8E6F092957E054A4C737C88B08A0CA734A","documentHash":"970718de-772b-4f7d-bfd6-c57521084383"}],"objectId":"63d64abf40970753829313c8","doi":"10.1200/jco.2022.40.16_suppl.e21544","publicUri":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2022.40.16_suppl.e21544","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"Is the BRAF mutation still an unfavorable risk factor in patients with metastatic melanoma in the era of modern therapies?","otherTitles":[],"abstracts":[],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c28b"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"40","issue":"16_suppl","pagesFromTo":"e21544-e21544","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["63d64abf40970753829313ca","63d64abf40970753829313cb","63d64abf40970753829313cc","63d64abf40970753829313cd","63d64abf40970753829313ce","63d64abf40970753829313cf","63d64abf40970753829313d0","63d64abf40970753829313d1","61ea28b875234061bbd3c28b","63d64abf40970753829313d3","63d64abf40970753829313d4","63d64abf40970753829313d5","63d64abf40970753829313d6","63d64abf40970753829313d7","63d64abf40970753829313d8","63d64abf40970753829313d9","63d64abf40970753829313da","63d64abf40970753829313db","63d64abf40970753829313dc","63d64abf40970753829313dd"]},"journal":{"objectId":"5e6f7d4d878c285145478574","mniswId":"10525","title":"JOURNAL OF CLINICAL ONCOLOGY","issn":"0732-183X","documentHash":"d6d8972d-de18-419d-93bc-f2c108e69090"},"_version":4,"journalIssue":{"objectId":"63d64abf40970753829313c9","year":"2022","volume":"40","number":"16_suppl","documentHash":"9c11fd4f-7c42-43f1-ac0e-d46b29dafced"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747654702203"},{"authors":[{"objectId":"6596a9d14097074a3905297a","name":"Jerzy","lastName":"Błaszczyk","documentHash":"54f98ffe-f6a5-4949-b55a-0af9e1862a01"},{"objectId":"6596a9d14097074a39052979","name":"Zbyszko","lastName":"Chowaniec","documentHash":"191f4ec2-55fb-4e58-844b-0240acb939d7"},{"objectId":"61ea28b875234061bbd3c29b","name":"Natasza","lastName":"Kempa-Kamińska","uuid":"6E3454023C2C2F3D25688B923C8B056B97F4DFE25D4F4AFAC17ABB328F88D647843891BC939AD61FB738060BB7FA73279D0A0EB707FBB179CB03D976F6B48AD1","documentHash":"0027317f-2101-46a7-8721-38d17fe4a474"},{"objectId":"61ea28b875234061bbd3c281","name":"Emilia","lastName":"Filipczyk-Cisarż","uuid":"5F0CC9CBBBE59951DC3EACEF09D88D0EF6B7E21F3F62DF0A15F5021EAF8A6893E894F2416B9A11DB606A638688EEC0DD235C55093F60B5AC42ACD5EC886366D8","documentHash":"8ed923f7-580d-4faa-898d-8fccc3167166"},{"objectId":"61ea28b875234061bbd3c227","name":"Mateusz","lastName":"Malik","uuid":"E10C5FF6B24F9CB3F38E63DAE9909766E2F3D709424B581C90C3872E6FBE84412764D5FC8754E23364225C5F44C9D53E3CFAC24320E755E9F2A13213197E48D6","documentHash":"5b20b002-b90f-4ba9-a4a6-f02935e0ea43"}],"objectId":"6596a9d14097074a39052977","doi":"10.5603/ocp.2023.0048","publicUri":"https://journals.viamedica.pl/oncology_in_clinical_practice/article/viewFile/95140/72964","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Predictive factors of hepatotoxicity in immunotherapy with checkpoint inhibitors in patients treated for melanoma and kidney cancer","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Introduction.\nCheckpoint inhibitors immunotherapy (CPI) is widely used in the treatment of malignant tumors and has a positive effect on patient prognosis. CPI treatment is associated with various immunological adverse events (AEs), including a rare one — immunological hepatitis. \n\nMaterial and methods.\nThis study aims to analyze hepatic AEs in patients undergoing CPI therapy and to attempt to determine hepatotoxicity predictors. A retrospective statistical analysis of medical records of 223 CPI patients treated in the years 2014–2021 in Lower Silesian Oncology, Pulmonology and Hematology Center in Wrocław was performed. \n\nResults.\nToxicity grade 1–4 according to the Common Terminology Criteria for Adverse Events (CTCAE) occurred in 26% of patients, of which 6% were grade 3–4. An increased risk of hepatotoxicity was found in the group of patients ≤ 60 years of age compared to the > 60-year-old group (34.1% vs. 21.7%, p = 0.0418). It has also been confirmed that the occurrence of hepatic AEs during first-line immunotherapy increases the risk of toxicity recurrence during second-line immunotherapy (58.3% vs. 15.4%, p = 0.0199). No significantly increased risk of hepatic AEs has been demonstrated in patients with liver metastases, hepatic steatosis, or other chronic liver disease, or in patients after chemotherapy, with elevated baseline levels of lactate dehydrogenase (LDH), or increased body mass index (BMI). \n\nConclusions.\nThe hepatotoxicity of CPI immunotherapy poses a significant diagnostic and therapeutic challenge. Its early detection and treatment according to the recommended algorithms increases patient safety for patients and sometimes allows the continuation of treatment."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c281","61ea28b875234061bbd3c29b","61ea28b875234061bbd3c227"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","articleEvaluation":{"indexedJournal":false,"isReview":true,"wosConference":false},"contributionOrder":{"AUTHOR":["61ea28b875234061bbd3c227","6596a9d14097074a39052979","61ea28b875234061bbd3c29b","6596a9d14097074a3905297a","61ea28b875234061bbd3c281"]},"journal":{"objectId":"5ebffdf8ad49b31ccece7147","title":"Oncology in Clinical Practice","doi":"","issn":" 2450-1654","eissn":"2450-6478","documentHash":"d4b1ee55-16bf-4be2-93f6-8b18996422cc"},"_version":4,"journalIssue":{"objectId":"6596a9d14097074a39052978","year":"2023","documentHash":"04eaf8db-153a-47e0-b060-274ff2aa8864"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747654783185"},{"authors":[{"objectId":"659692b24097074a3902a0d7","name":"Mark","lastName":"Kochenderfer","documentHash":"4de83c0c-47ba-4fb9-a301-89a1589925b8"},{"objectId":"659692b24097074a3902a0d6","name":"Timothy","lastName":"Larson","documentHash":"acefd363-fbb9-4da1-a813-1dff0e8e919a"},{"objectId":"659692b24097074a3902a0d5","name":"Farshid","lastName":"Dayyani","documentHash":"f017a8d4-2742-4365-bc4d-692e8c2029e9"},{"objectId":"659692b24097074a3902a0d4","name":"Zev","lastName":"Wainberg","documentHash":"539f87cb-6b07-4bcd-afa8-7f4841b90cfd"},{"objectId":"659692b24097074a3902a0d3","name":"Richard","lastName":"Dunne","documentHash":"881298a9-3f1f-4159-8702-13bc4e3c9dcd"},{"objectId":"659692b24097074a3902a0d2","name":"Moses","lastName":"Raj","documentHash":"7310a37a-0ef0-49d9-a560-9556cadc4d6c"},{"objectId":"659692b24097074a3902a0d1","name":"Lindsay","lastName":"Overton","documentHash":"e15c7be0-5b2f-42c5-b518-037298f4a724"},{"objectId":"659692b24097074a3902a0d0","name":"Paul","lastName":"Celano","documentHash":"92d782b5-8fe9-43db-80b6-e2cf1d32e702"},{"objectId":"659692b24097074a3902a0cf","name":"Kai-Keen","lastName":"Shiu","documentHash":"9b2de9a1-0526-4976-9e10-82f94995f8e0"},{"objectId":"659692b24097074a3902a0ce","name":"Louise","lastName":"Medley","documentHash":"3e3cd24c-7209-4671-947d-ddf96273ff2d"},{"objectId":"659692b24097074a3902a0cd","name":"Anna-Mary","lastName":"Young","documentHash":"411c5e95-f13c-428e-b98a-3a80a716267e"},{"objectId":"659692b24097074a3902a0cc","name":"Rajarshi","lastName":"Roy","documentHash":"931d008b-a58d-4564-ac1b-b525689a6825"},{"objectId":"659692b24097074a3902a0cb","name":"Nataliia","lastName":"Voitko","documentHash":"821eadff-9d0c-44ca-845d-3e9e5b456a8c"},{"objectId":"659692b24097074a3902a0ca","name":"Dmytro","lastName":"Trukhin","documentHash":"2e02c809-d89a-4444-a028-7fe40189dfd8"},{"objectId":"659692b24097074a3902a0c9","name":"Yaroslav","lastName":"Shparyk","documentHash":"b15ac2c0-1ee2-4313-85ea-f2252b25ce3d"},{"objectId":"659692b24097074a3902a0c8","name":"Ievgen","lastName":"Ilin","documentHash":"e7fb32c7-f70a-4d6d-a988-f9b609b215d8"},{"objectId":"659692b24097074a3902a0c7","name":"Lurii","lastName":"Leshchenko","documentHash":"42d1df23-f9b5-432c-9457-ada4f65d2f46"},{"objectId":"659692b24097074a3902a0c6","name":"Anna","lastName":"Kryzhanivska","documentHash":"52061126-30b2-4248-947c-5fc60e1da2cb"},{"objectId":"659692b24097074a3902a0c5","name":"Yuriy","lastName":"Ostapenko","documentHash":"e9069b48-33c8-48c2-98f2-7d1a3d13217d"},{"objectId":"659692b24097074a3902a0c4","name":"Oleksii","lastName":"Kolesnik","documentHash":"3fc48b73-4e3d-4da1-a5d1-86537da576ef"},{"objectId":"659692b24097074a3902a0c3","name":"Igor","lastName":"Bondarenko","documentHash":"ce9fa1a2-25ad-47d3-9ed5-5d42963cdc2a"},{"objectId":"659692b24097074a3902a0c2","name":"Hryhoriy","lastName":"Adamchuk","documentHash":"3198e34b-ecb4-474d-92bc-203937a6b960"},{"objectId":"659692b24097074a3902a0c1","name":"Suayib","lastName":"Yalcin","documentHash":"6a8dda53-ced2-4fe6-bbcf-51927f87262c"},{"objectId":"659692b24097074a3902a0c0","name":"Bulent","lastName":"Erdogan","documentHash":"703c4300-a2da-4121-b3e7-579a1690a869"},{"objectId":"659692b24097074a3902a0bf","name":"Ilhan","lastName":"Hacibekiroglu","documentHash":"df9020d0-568e-42ff-bbd0-3f4a6b6e0bda"},{"objectId":"659692b24097074a3902a0be","name":"Aziz","lastName":"Karaoglu","documentHash":"8793ad49-5e90-449e-8155-71e0b0181e88"},{"objectId":"659692b24097074a3902a0bd","name":"Hakan","lastName":"Harputluoglu","documentHash":"79491b57-59c1-45c2-8cb2-d3f526a25099"},{"objectId":"659692b24097074a3902a0bc","name":"Berna","lastName":"Oksuzoglu","documentHash":"f88b9c08-4f43-4677-afbe-1614831b4797"},{"objectId":"659692b24097074a3902a0bb","name":"Timucin","lastName":"Cil","documentHash":"56fbc43b-a680-4284-adc1-78b3afca44a3"},{"objectId":"659692b24097074a3902a0ba","name":"Mustafa","lastName":"Ozguroglu","documentHash":"d39121bb-3213-48f0-906e-e1d5ca012c8d"},{"objectId":"659692b24097074a3902a0b9","name":"Mehmet","lastName":"Bilici","documentHash":"0ab40c76-1241-4a03-ae58-f753ef2f14b2"},{"objectId":"659692b24097074a3902a0b8","name":"Johnson","lastName":"Lin","documentHash":"33d155cb-b3ad-4cd9-a23b-1db230cff07d"},{"objectId":"659692b24097074a3902a0b7","name":"Yen-Yang","lastName":"Chen","documentHash":"e181b1b3-ab61-46d7-a61a-9b042b7bf815"},{"objectId":"659692b24097074a3902a0b6","name":"Chia-Jui","lastName":"Yen","documentHash":"e028d3b2-8386-4573-bd12-438a31e86d32"},{"objectId":"659692b24097074a3902a0b5","name":"Kun-Huei","lastName":"Yeh","documentHash":"dbc5de6c-4d36-4406-a0b3-6a8eee19b5fe"},{"objectId":"659692b24097074a3902a0b4","name":"Thibaud","lastName":"Kossler","documentHash":"8bac7026-dead-4862-8c3e-a42aee890d3c"},{"objectId":"659692b24097074a3902a0b3","name":"Sara De","lastName":"Dosso","documentHash":"6c052849-348f-40b1-8086-01a0abeb09e4"},{"objectId":"659692b24097074a3902a0b2","name":"Ralph","lastName":"Winterhalder","documentHash":"dfef733c-6411-474c-bf8d-d960141bc572"},{"objectId":"659692b24097074a3902a0b1","name":"Sara","lastName":"Bastian","documentHash":"a74ab3c8-ad43-4f9e-b96f-103bcb9265db"},{"objectId":"659692b24097074a3902a0b0","name":"Ralph","lastName":"Fritsch","documentHash":"1beddba1-0488-4c7e-8294-4b39bf077940"},{"objectId":"659692b24097074a3902a0af","name":"Laura","lastName":"Layos Romero","documentHash":"35117abb-0db9-43cf-b02e-ba8183d325aa"},{"objectId":"659692b24097074a3902a0ae","name":"Jesus","lastName":"Miranda Poma","documentHash":"bf80216c-3ed3-4be5-84c7-aa453d01c397"},{"objectId":"659692b24097074a3902a0ad","name":"Fernando","lastName":"Rivera Herrero","documentHash":"0b29f6c5-17ad-4d5f-87e6-ea230d3c6223"},{"objectId":"659692b24097074a3902a0ac","name":"Javier","lastName":"Gallego Plazas","documentHash":"eb56dcee-1022-4f19-94e6-974a379b2ef2"},{"objectId":"659692b24097074a3902a0ab","name":"Paula","lastName":"Jimenez Fonseca","documentHash":"bf0921e8-a302-4908-a5e1-a70ad2cd95d4"},{"objectId":"659692b24097074a3902a0aa","name":"Marc","lastName":"Diez Garcia","documentHash":"9de66767-6491-4e45-ba2c-d6186d65c9ee"},{"objectId":"659692b24097074a3902a0a9","name":"Jean-Marc","lastName":"Maurel","documentHash":"c1e384ea-7305-412f-8f0d-273c16e8a286"},{"objectId":"659692b24097074a3902a0a8","name":"Elizabeth","lastName":"Schoeman","documentHash":"bd5b3bf8-b6d5-4a93-86ba-d203da80a9b5"},{"objectId":"659692b24097074a3902a0a7","name":"Paul","lastName":"Ruff","documentHash":"c396b048-d382-41ba-ba64-27a844eafdd1"},{"objectId":"659692b24097074a3902a0a6","name":"Barbara","lastName":"Robertson","documentHash":"e1c1b797-1425-406b-b2d8-e452436401c8"},{"objectId":"659692b24097074a3902a0a5","name":"Gregory","lastName":"Landers","documentHash":"adcef298-af8d-4b68-976b-0477e7c58b59"},{"objectId":"659692b24097074a3902a0a4","name":"Peter","lastName":"Kraus","documentHash":"4daddcab-e324-4afb-8d7a-9db2bcb95a94"},{"objectId":"659692b24097074a3902a0a3","name":"Conrad","lastName":"Jacobs","documentHash":"918e5324-d914-4246-b756-b70b2937e90a"},{"objectId":"659692b24097074a3902a0a2","name":"Sze","lastName":"Chan","documentHash":"22f6d56b-91fc-4a40-93dc-551d156cd2e7"},{"objectId":"659692b24097074a3902a0a1","name":"Maria","lastName":"Smagina","documentHash":"03158561-af89-46fc-88e8-8a37cd45ce3a"},{"objectId":"659692b24097074a3902a0a0","name":"Dmitry","lastName":"Nosov","documentHash":"a01af678-b492-4dda-9d5b-2df6963a1769"},{"objectId":"659692b24097074a3902a09f","name":"Yulia","lastName":"Makarycheva","documentHash":"f01e7689-0c1d-4cd3-a26a-1d5655488444"},{"objectId":"659692b24097074a3902a09e","name":"Natalia","lastName":"Fadeeva","documentHash":"eb1fc0f6-83a3-4b34-9631-12e49987340d"},{"objectId":"659692b24097074a3902a09d","name":"Sergey","lastName":"Tjulandin","documentHash":"38f05484-8f54-44aa-81c4-3d0e72281c21"},{"objectId":"659692b24097074a3902a09c","name":"Rashida","lastName":"Orlova","documentHash":"5251dd89-c4a7-4519-9990-08a64bd59e3a"},{"objectId":"659692b24097074a3902a09b","name":"Do-Youn","lastName":"Oh","documentHash":"f381fbdc-6f5b-469e-bb8a-cf5ab2015324"},{"objectId":"659692b24097074a3902a09a","name":"Min-Hee","lastName":"Ryu","documentHash":"0639d262-8622-4ff3-ba76-0cac5f71612e"},{"objectId":"659692b24097074a3902a099","name":"Jeeyun","lastName":"Lee","documentHash":"eaf9b7b9-814a-4861-9ade-d5205f950833"},{"objectId":"659692b24097074a3902a098","name":"Sun Young","lastName":"Rha","documentHash":"0b665a0e-1ff7-481d-be14-5ecae6984d95"},{"objectId":"659692b24097074a3902a097","name":"Boguslawa","lastName":"Karaszewska","documentHash":"6a43a91a-cd2e-4506-bd8b-4506b5d92f31"},{"objectId":"659692b24097074a3902a096","name":"Jakub","lastName":"Zolnierek","documentHash":"bf8918f1-fd4b-4cef-b519-62b0f6f461d9"},{"objectId":"659692b24097074a3902a095","name":"Piotr","lastName":"Wysocki","documentHash":"cc1ab62f-f52f-426a-ae42-ea3c79eafb1a"},{"objectId":"659692b24097074a3902a094","name":"Lucjan","lastName":"Wyrwicz","documentHash":"7c278642-5cb6-49b6-b719-06fc3e047c99"},{"objectId":"659692b24097074a3902a093","name":"Cesar","lastName":"Torres","documentHash":"eba31e83-b9ba-4608-a0bd-fd850b6f20bf"},{"objectId":"659692b24097074a3902a092","name":"Julio","lastName":"Grados","documentHash":"db90aab7-9646-4740-b588-aff08f5abf02"},{"objectId":"659692b24097074a3902a091","name":"Victor","lastName":"Castro Oliden","documentHash":"3fcfa706-3d57-4cc6-a2e3-edb1254567e8"},{"objectId":"659692b24097074a3902a090","name":"Dragan","lastName":"Damianovich","documentHash":"6da2d94e-5fc7-45a8-9c6f-8e30b8c61e21"},{"objectId":"659692b24097074a3902a08f","name":"Paola","lastName":"Balancan","documentHash":"88f2d372-e937-4f4e-952d-90ac0ed38f6f"},{"objectId":"659692b24097074a3902a08e","name":"Francisco","lastName":"Ramirez Godinez","documentHash":"b41d007c-18b8-4669-82f7-297b55b0aae8"},{"objectId":"659692b24097074a3902a08d","name":"Fidel","lastName":"Huitzil Melendez","documentHash":"9c1c1514-26cd-4a97-bed7-342c2a974277"},{"objectId":"659692b24097074a3902a08c","name":"Marytere","lastName":"Herrera Martinez","documentHash":"4f168fdd-a43f-4ae9-b4be-a4f5d3974be4"},{"objectId":"659692b24097074a3902a08b","name":"Jorge","lastName":"Martinez Rodriguez","documentHash":"869a5d4c-4ca6-443d-bb87-2db33e29f39e"},{"objectId":"659692b24097074a3902a08a","name":"Shigenori","lastName":"Kadowaki","documentHash":"0f6896eb-1f78-4c58-b125-3347a21b0a8c"},{"objectId":"659692b24097074a3902a089","name":"Kenji","lastName":"Ishido","documentHash":"02582b71-7e37-4add-8ce9-d577bedca52b"},{"objectId":"659692b24097074a3902a088","name":"Akihito","lastName":"Kawazoe","documentHash":"2b3b010d-a4b5-454b-9aa6-45dead4d1483"},{"objectId":"659692b24097074a3902a087","name":"Hisato","lastName":"Kawakami","documentHash":"98028ea1-3b6f-439e-953f-8d0188542066"},{"objectId":"659692b24097074a3902a086","name":"Akihito","lastName":"Tsuji","documentHash":"df78b0f7-dad9-432d-8dcf-2df0fd4e953c"},{"objectId":"659692b24097074a3902a085","name":"Takashi","lastName":"Oshima","documentHash":"175553ae-22dc-4b67-a44e-73b3cbda2ee5"},{"objectId":"659692b24097074a3902a084","name":"Hiroshi","lastName":"Yabusaki","documentHash":"0dc5145b-1411-4b38-a626-5f11f14e197a"},{"objectId":"659692b24097074a3902a083","name":"Taito","lastName":"Esaki","documentHash":"a07546ca-4d9a-4549-9231-5a0c0c90a75a"},{"objectId":"659692b24097074a3902a082","name":"Yasuhiro","lastName":"Choda","documentHash":"a5fada10-cdce-4015-b684-c96fc337206f"},{"objectId":"659692b24097074a3902a081","name":"Kenji","lastName":"Amagai","documentHash":"e99c341c-ece4-4047-9b8f-9f42d17134dd"},{"objectId":"659692b24097074a3902a080","name":"Kensei","lastName":"Yamaguchi","documentHash":"5a8b841e-c2c0-4a5d-9777-6ce44721d14d"},{"objectId":"659692b24097074a3902a07f","name":"Nobuhiro","lastName":"Shibata","documentHash":"8d044e8c-8f6f-4094-bdfa-3e44b97e55a6"},{"objectId":"659692b24097074a3902a07e","name":"Naotoshi","lastName":"Sugimoto","documentHash":"6277b7e1-e451-44f3-86f8-94cf10c25222"},{"objectId":"659692b24097074a3902a07d","name":"Hirokazu","lastName":"Shoji","documentHash":"4e225bec-a90f-4830-8f8f-0860024332ef"},{"objectId":"659692b24097074a3902a07c","name":"Tatsu","lastName":"Shimoyama","documentHash":"10b4fc67-7e28-41b8-abd8-a022ddb38ee1"},{"objectId":"659692b24097074a3902a07b","name":"Masahiro","lastName":"Tsuda","documentHash":"3f10f968-0dbd-499d-a169-3125a95c4f43"},{"objectId":"659692b24097074a3902a07a","name":"Hisateru","lastName":"Yasui","documentHash":"6f46546c-f00d-429f-946d-9b14fde2cf17"},{"objectId":"659692b24097074a3902a079","name":"Shiro","lastName":"Iwagami","documentHash":"7b2d196e-4e80-48ba-9e31-0c40a061073e"},{"objectId":"659692b24097074a3902a078","name":"Hiroki","lastName":"Hara","documentHash":"eea4bd9f-d04f-45e1-9ae9-34fb5a4e34b7"},{"objectId":"659692b24097074a3902a077","name":"Taroh","lastName":"Satoh","documentHash":"8bbe9dd7-98aa-4f68-87e2-aaa7cc4575d9"},{"objectId":"659692b24097074a3902a076","name":"Carlo","lastName":"Garufi","documentHash":"a4c2c754-1db9-43de-aa81-334eb0426331"},{"objectId":"659692b24097074a3902a075","name":"Sara","lastName":"Lonardi","documentHash":"27d23463-b4d2-47b1-97a6-82648f4a85ba"},{"objectId":"659692b24097074a3902a074","name":"Nicola","lastName":"Fazio","documentHash":"b8fac4cd-87c5-4692-a2ba-d6c5aa3bfaee"},{"objectId":"659692b24097074a3902a073","name":"Maria","lastName":"Di Bartolomeo","documentHash":"e1cf5fba-604d-4f8a-af5c-0c12d4be05c9"},{"objectId":"659692b24097074a3902a072","name":"Moshe","lastName":"Mishaeli","documentHash":"3847393b-81f5-4c63-bb7f-6b8c734f5c10"},{"objectId":"659692b24097074a3902a071","name":"Ronen","lastName":"Brenner","documentHash":"403ae9b8-4266-45c8-b528-25e16d4b8ef2"},{"objectId":"659692b24097074a3902a070","name":"Sharon","lastName":"Pelles Avraham","documentHash":"4418c74c-a38c-4df3-87f4-2818b98a6ae2"},{"objectId":"659692b24097074a3902a06f","name":"Sofia","lastName":"Man","documentHash":"151a2cb6-5fca-4fc2-9f01-35f2b80cb4dc"},{"objectId":"659692b24097074a3902a06e","name":"Einat","lastName":"Shacham-Shmueli","documentHash":"1b54b88c-7133-44a3-b26d-85f3af364106"},{"objectId":"659692b24097074a3902a06d","name":"Irit","lastName":"Ben-Aharon","documentHash":"ee23f11e-77f1-4223-abd9-a2b405a5b1c2"},{"objectId":"659692b24097074a3902a06c","name":"Baruch","lastName":"Brenner","documentHash":"f2be5134-ccef-40bf-bf87-9cca12184d76"},{"objectId":"659692b24097074a3902a06b","name":"Ayala","lastName":"Hubert","documentHash":"9204f686-67ba-4a12-bfc0-fb0ef839ce23"},{"objectId":"659692b24097074a3902a06a","name":"Patrick","lastName":"Morris","documentHash":"762f4fdd-086b-46eb-b58c-5081e14ff9af"},{"objectId":"659692b24097074a3902a069","name":"Ray","lastName":"McDermott","documentHash":"29469a47-07fd-4669-9ed4-a1a9fc2de946"},{"objectId":"659692b24097074a3902a068","name":"Maeve","lastName":"Lowery","documentHash":"0a6103a2-f8df-451c-8da1-4d8be3eb294a"},{"objectId":"659692b24097074a3902a067","name":"Zsolt","lastName":"Horvath","documentHash":"bd34b825-3be1-4ecc-a16a-59f021b891e4"},{"objectId":"659692b24097074a3902a066","name":"Erika","lastName":"Hitre","documentHash":"747a27fa-36ee-4647-b2a3-656a90c73c7c"},{"objectId":"659692b24097074a3902a065","name":"Tibor","lastName":"Csoszi","documentHash":"f87b84af-ada0-4e47-8814-2e9e1f683a49"},{"objectId":"659692b24097074a3902a064","name":"Peter","lastName":"Arkosy","documentHash":"d9c785bc-342e-421c-90d4-2879de35cb05"},{"objectId":"659692b24097074a3902a063","name":"Winnie","lastName":"Yeo","documentHash":"fc7aa829-a33b-4a57-b1c2-3f5a63419bbe"},{"objectId":"659692b24097074a3902a062","name":"Ashley","lastName":"Cheng","documentHash":"42f746e8-e71f-4744-8bbd-1f837760d6e7"},{"objectId":"659692b24097074a3902a061","name":"Wendy","lastName":"Chan","documentHash":"3629f3e5-89d4-4aa5-92be-5b8b82a2b780"},{"objectId":"659692b24097074a3902a060","name":"Marco","lastName":"Chivalan","documentHash":"a8a05378-d774-46d6-b50d-cd7ca4d18a6a"},{"objectId":"659692b24097074a3902a05f","name":"Mynor","lastName":"Aguilar","documentHash":"ecd06e2d-24f4-4ade-b086-a1c28b7fbf50"},{"objectId":"659692b24097074a3902a05e","name":"Julio","lastName":"Ramirez","documentHash":"155ec218-af0b-4b47-bb91-db84c73ef2b1"},{"objectId":"659692b24097074a3902a05d","name":"Karla","lastName":"Lopez","documentHash":"7feedd08-de55-46e6-aa5f-894c3c82f684"},{"objectId":"659692b24097074a3902a05c","name":"Hugo","lastName":"Castro","documentHash":"dff0edec-4cb5-444e-96b0-cdb43eb1baf1"},{"objectId":"659692b24097074a3902a05b","name":"Alexander","lastName":"Stein","documentHash":"21680efd-dd5b-41c6-86f8-d5f053bbf4b6"},{"objectId":"659692b24097074a3902a05a","name":"Florian","lastName":"Lordick","documentHash":"5aa59296-73e0-48e7-8168-c93bfd2547e8"},{"objectId":"659692b24097074a3902a059","name":"Uwe","lastName":"Martens","documentHash":"0bd140af-6f8c-40a8-a5e7-f79ca740b778"},{"objectId":"659692b24097074a3902a058","name":"Dirk","lastName":"Arnold","documentHash":"578bd6b0-433a-4756-91bd-f2a0b6526686"},{"objectId":"659692b24097074a3902a057","name":"Jean-Philippe","lastName":"Metges","documentHash":"b8d3f4ea-99ab-4a31-a524-fdc37062cd67"},{"objectId":"659692b24097074a3902a056","name":"Frederic","lastName":"Di Fiore","documentHash":"78844f5d-4609-49a8-9605-801de76ead2d"},{"objectId":"659692b24097074a3902a055","name":"Sandrine","lastName":"Hiret","documentHash":"3484b63c-17ab-4cc5-965d-39bc33df58a3"},{"objectId":"659692b24097074a3902a054","name":"Diane","lastName":"Pannier","documentHash":"b4996e23-5599-459a-8ba5-158199cc1c44"},{"objectId":"659692b24097074a3902a053","name":"Christophe","lastName":"Borg","documentHash":"fdf36495-0929-4a38-8ecc-b5b13f039e4e"},{"objectId":"659692b24097074a3902a052","name":"Daniel","lastName":"Lopez-Trabada","documentHash":"256066a6-db8c-4511-a71b-2842d9fc370f"},{"objectId":"659692b24097074a3902a051","name":"Valerie","lastName":"Boige","documentHash":"bc88d540-f513-4d05-88f3-d683c1dc0852"},{"objectId":"659692b24097074a3902a050","name":"Mette","lastName":"Yilmaz","documentHash":"cba0ddcf-56f9-4458-837e-d841494faede"},{"objectId":"659692b24097074a3902a04f","name":"Lene","lastName":"Baeksgaard","documentHash":"3770177b-394e-4a6e-93ec-d06d31a1aa59"},{"objectId":"659692b24097074a3902a04e","name":"Per","lastName":"Pfeiffer","documentHash":"80bf9200-982f-4291-ae8a-500ca0d63775"},{"objectId":"659692b24097074a3902a04d","name":"Jakub","lastName":"Cvek","documentHash":"1267be7f-72c5-446a-a2f4-eb77d1c16395"},{"objectId":"659692b24097074a3902a04c","name":"David","lastName":"Vrana","documentHash":"7e38cef6-02e9-4c53-a5da-8b4f7a7ccc86"},{"objectId":"659692b24097074a3902a04b","name":"Radka","lastName":"Obermannova","documentHash":"305b4ce2-c98b-4f85-9024-fed7b78ceff6"},{"objectId":"659692b24097074a3902a04a","name":"Tomas","lastName":"Svoboda","documentHash":"a9be42cf-d308-4e5e-8766-b6d44010cd09"},{"objectId":"659692b24097074a3902a049","name":"Tomas","lastName":"Buchler","documentHash":"d997584e-5f24-44d3-a5b8-f860eaef5558"},{"objectId":"659692b24097074a3902a048","name":"Bohuslav","lastName":"Melichar","documentHash":"14c6f7e8-e1bf-4c8c-8078-a318a87806cf"},{"objectId":"659692b24097074a3902a047","name":"Ileana","lastName":"Gonzalez Herrera","documentHash":"3a2900a4-1318-4108-b284-77d71b54c84e"},{"objectId":"659692b24097074a3902a046","name":"Luis","lastName":"Corrales","documentHash":"5cdcbd2d-3b1b-4438-b3cc-fdc0762e3914"},{"objectId":"659692b24097074a3902a045","name":"Adrian","lastName":"Guzman Ramirez","documentHash":"a2a906be-5886-4597-9817-1dc6480660e0"},{"objectId":"659692b24097074a3902a044","name":"Ray","lastName":"Manneh Kopp","documentHash":"966953a2-0b80-41cb-a76c-9ac575338b78"},{"objectId":"659692b24097074a3902a043","name":"Manuel","lastName":"Gonzalez Fernandez","documentHash":"e457aaa7-442e-4577-9f66-a387d3a2c730"},{"objectId":"659692b24097074a3902a042","name":"Juan","lastName":"Rubiano","documentHash":"82470f49-8777-4fbc-9a7f-dee5e96988b9"},{"objectId":"659692b24097074a3902a041","name":"Alvaro","lastName":"Guerrero","documentHash":"c348a734-f69d-4960-8016-26af2e09098e"},{"objectId":"659692b24097074a3902a040","name":"Shouguo","lastName":"Li","documentHash":"3f4af0e3-a2fa-48f5-9187-3b2fc65e721d"},{"objectId":"659692b24097074a3902a03f","name":"Guoqing","lastName":"Lv","documentHash":"8b75652f-2acc-44e0-885b-22cc79129622"},{"objectId":"659692b24097074a3902a03e","name":"Yang","lastName":"Ling","documentHash":"8b87bd73-995f-43c7-9a4e-fb4632f8d97e"},{"objectId":"659692b24097074a3902a03d","name":"Junhe","lastName":"Li","documentHash":"836ff79d-3659-4665-bb4b-4068515af880"},{"objectId":"659692b24097074a3902a03c","name":"Xianli","lastName":"Yin","documentHash":"a625ff14-493d-4590-a7b4-5e88d5cfdf23"},{"objectId":"659692b24097074a3902a03b","name":"Qun","lastName":"Zhao","documentHash":"0bdd80f0-db8f-448e-b1e7-338cef575ad4"},{"objectId":"659692b24097074a3902a03a","name":"Xinjun","lastName":"Liang","documentHash":"c3a1dda3-262c-4524-8813-7a3354b3919d"},{"objectId":"659692b24097074a3902a039","name":"Jianwei","lastName":"Lu","documentHash":"81ea4f04-84fd-4c5b-9963-a4912f95551c"},{"objectId":"659692b24097074a3902a038","name":"Feng","lastName":"Ye","documentHash":"a1e8c13b-7b43-4d01-b981-0bb3b83e771c"},{"objectId":"659692b24097074a3902a037","name":"Enxiao","lastName":"Li","documentHash":"f95c3916-08ef-4419-be45-42dbe8c9492b"},{"objectId":"659692b24097074a3902a036","name":"Hongming","lastName":"Pan","documentHash":"fff51a72-950c-42e0-9555-4f63f8629279"},{"objectId":"659692b24097074a3902a035","name":"Ping","lastName":"Chen","documentHash":"87de6b5a-6f2a-4176-9465-453cceaa6486"},{"objectId":"659692b24097074a3902a034","name":"Lin","lastName":"Zhao","documentHash":"649c13fa-37ef-4742-b0fd-71eb1b822235"},{"objectId":"659692b24097074a3902a033","name":"Lin","lastName":"Yang","documentHash":"360a2321-2f21-4748-bd9b-257957e1b906"},{"objectId":"659692b24097074a3902a032","name":"Yanli","lastName":"Qu","documentHash":"bfda2ae4-d3b2-4b6d-8f44-9b6f04640197"},{"objectId":"659692b24097074a3902a031","name":"Shan","lastName":"Zeng","documentHash":"2c1aca76-8720-4c47-85fe-8c0d7d084154"},{"objectId":"659692b24097074a3902a030","name":"Xi","lastName":"Chen","documentHash":"627eae5b-ad95-4a73-bda9-49ac5eadc0c9"},{"objectId":"659692b24097074a3902a02f","name":"Jieer","lastName":"Ying","documentHash":"6bdd84cf-ddec-43f0-aee0-5a5fed45ffce"},{"objectId":"659692b24097074a3902a02e","name":"Wei","lastName":"Li","documentHash":"33216e99-40e6-4091-a48a-0334b4990809"},{"objectId":"659692b24097074a3902a02d","name":"Suxia","lastName":"Luo","documentHash":"ace8549b-cc03-4232-883a-641c239a77d1"},{"objectId":"659692b24097074a3902a02c","name":"Jianwei","lastName":"Yang","documentHash":"c2ab34df-217f-48f3-9325-b1b140403065"},{"objectId":"659692b24097074a3902a02b","name":"Shukui","lastName":"Qin","documentHash":"901af9ab-0f9b-4b2a-89c7-6c9c30d15e37"},{"objectId":"659692b24097074a3902a02a","name":"Xiaoyan","lastName":"Lin","documentHash":"861c1740-fd9b-49d3-be85-0c353c81da21"},{"objectId":"659692b24097074a3902a029","name":"Tianshu","lastName":"Liu","documentHash":"2bc5e1d1-ec2f-4b64-a081-31a53cd01eb7"},{"objectId":"659692b24097074a3902a028","name":"Xiaochun","lastName":"Zhang","documentHash":"6570e303-198a-4a91-a6a2-9801d6baa690"},{"objectId":"659692b24097074a3902a027","name":"Jin","lastName":"Li","documentHash":"8d1d6bc9-13ad-4de4-b907-0b960d6da122"},{"objectId":"659692b24097074a3902a026","name":"Yuxian","lastName":"Bai","documentHash":"e8deedf2-d317-48a7-bbf6-f79866eb28fe"},{"objectId":"659692b24097074a3902a025","name":"Pamela","lastName":"Salman","documentHash":"3ecdc93b-8d7b-461d-ad78-b8978938341a"},{"objectId":"659692b24097074a3902a024","name":"Cesar","lastName":"Sanchez","documentHash":"ac0750c0-4bd9-437a-8224-e8393b4b39ce"},{"objectId":"659692b24097074a3902a023","name":"Mauricio","lastName":"Mahave","documentHash":"d2cd7b55-60f9-4eb8-be97-e2dac965a00d"},{"objectId":"659692b24097074a3902a022","name":"Patricio","lastName":"Yanez Weber","documentHash":"5368edf9-e022-4489-aec5-0b8f59d46eab"},{"objectId":"659692b24097074a3902a021","name":"Jamil","lastName":"Asselah","documentHash":"54e2a412-f48a-4f42-98e9-8f76ce49820d"},{"objectId":"659692b24097074a3902a020","name":"Ann","lastName":"Tan","documentHash":"f9adfbe6-ddff-4f07-b4f6-ccdca612399c"},{"objectId":"659692b24097074a3902a01f","name":"Raymond","lastName":"Jang","documentHash":"cb38d57a-f901-4c9c-bc97-58f64f6d2e0b"},{"objectId":"659692b24097074a3902a01e","name":"Scott","lastName":"Berry","documentHash":"7a38da12-81f2-4fa9-9d50-f98e4f97b94e"},{"objectId":"659692b24097074a3902a01d","name":"Michael","lastName":"Raphael","documentHash":"42b7fd3e-aa0c-40d9-9fb6-c49bbe8afeb8"},{"objectId":"659692b24097074a3902a01c","name":"Maria Marcela","lastName":"Monteiro","documentHash":"f769b7d3-16af-4be8-ac27-d69465e18440"},{"objectId":"659692b24097074a3902a01b","name":"Karina","lastName":"Vianna","documentHash":"37a9ae98-afb7-4562-b2b0-908837bc5996"},{"objectId":"659692b24097074a3902a01a","name":"Felipe Jose","lastName":"Cruz","documentHash":"4314329c-897c-4466-841d-0f7ac0cb9200"},{"objectId":"659692b24097074a3902a019","name":"Gustavo","lastName":"Alves","documentHash":"4f71b64e-a8e4-460b-a274-3a538f2896c8"},{"objectId":"659692b24097074a3902a018","name":"Fabio","lastName":"Franke","documentHash":"a60bdc8a-ee49-47ec-85c4-b6c172cf31a7"},{"objectId":"659692b24097074a3902a017","name":"Carlos","lastName":"Andrade","documentHash":"2faffafe-d6b0-4485-aa56-d91006f83062"},{"objectId":"659692b24097074a3902a016","name":"Mauricio","lastName":"Peressoni","documentHash":"832525a8-9bb8-448a-b91c-7b8293f22f4d"},{"objectId":"659692b24097074a3902a015","name":"Morteza","lastName":"Aghmesheh","documentHash":"f8ffc36b-6361-4dde-b12e-7a49811165d5"},{"objectId":"659692b24097074a3902a014","name":"Weng","lastName":"Ng","documentHash":"444664f1-b3ac-4cfd-8dfe-1110147527c2"},{"objectId":"659692b24097074a3902a013","name":"Rachel","lastName":"Wong","documentHash":"b5bde5f4-b10f-4c84-9ab0-07583ad2dab7"},{"objectId":"659692b24097074a3902a012","name":"Diego","lastName":"Kaen","documentHash":"fe9b45d3-c837-49ef-b215-a521c105521c"},{"objectId":"659692b24097074a3902a011","name":"Juan","lastName":"Cundom","documentHash":"00431add-4bb8-4c17-94c1-863c85b862bb"},{"objectId":"659692b24097074a3902a010","name":"Alvaro","lastName":"Yanzi Castilla","documentHash":"d499739e-f0f2-48e3-b8e0-1de0b317e49f"},{"objectId":"659692b24097074a3902a00f","name":"Juan Manuel","lastName":"O'Connor","documentHash":"4c7a6a89-5da8-467d-84b4-25ee62e17d68"},{"objectId":"659692b24097074a3902a00e","name":"Guillermo","lastName":"Mendez","documentHash":"609fc4d4-a9ab-410a-899d-544c7cc07fbe"},{"objectId":"659692b24097074a3902a00c","name":"Pooja","lastName":"Bhagia","documentHash":"58fd63f1-288d-4dad-abc5-44af8fcc5fe3"},{"objectId":"659692b24097074a3902a00b","name":"Sonal","lastName":"Bordia","documentHash":"80864ead-63a5-42a3-be35-f47d9781e542"},{"objectId":"659692b24097074a3902a00a","name":"Lina","lastName":"Yin","documentHash":"006185fa-3f3c-4425-8b37-dba6e2e0e3a7"},{"objectId":"659692b24097074a3902a009","name":"Zev A","lastName":"Wainberg","documentHash":"4e0b090e-9afa-42fa-830f-f14fff391eee"},{"objectId":"659692b24097074a3902a008","name":"Hongming","lastName":"Pan","documentHash":"141bca63-d209-42fd-b071-0896949e4798"},{"objectId":"659692b24097074a3902a007","name":"Suxia","lastName":"Luo","documentHash":"757b43da-b16e-4a64-bedd-adc43d423988"},{"objectId":"659692b24097074a3902a006","name":"Shukui","lastName":"Qin","documentHash":"1bb295ab-9853-4678-a389-809e7a638e28"},{"objectId":"659692b24097074a3902a005","name":"Felipe Melo","lastName":"Cruz","documentHash":"eadee9a5-617a-4bd2-ac52-66f42b2266f2"},{"objectId":"659692b24097074a3902a004","name":"Timuçin","lastName":"Çil","documentHash":"d004b9ee-4b31-4247-8a6d-0f153a108d77"},{"objectId":"659692b24097074a3902a003","name":"Maeve A","lastName":"Lowery","documentHash":"98d6c0aa-1969-40e1-8162-8786691d9293"},{"objectId":"659692b24097074a3902a002","name":"Jin","lastName":"Li","documentHash":"1fd39643-b73a-45f4-98b5-e49b5d921efc"},{"objectId":"659692b24097074a3902a001","name":"Manuel González","lastName":"Fernández","documentHash":"17110372-6d3b-4282-a4f3-f8831606525e"},{"objectId":"659692b24097074a3902a000","name":"Kai-Keen","lastName":"Shiu","documentHash":"d09e8497-7747-4996-9564-c0b6337753d8"},{"objectId":"659692b24097074a39029fff","name":"Marcelo","lastName":"Garrido","documentHash":"84b58830-0950-41fd-9d29-f8dc0b426a54"},{"objectId":"659692b24097074a39029ffe","name":"Gustavo Vasconcelos","lastName":"Alves","documentHash":"bbbe5a95-ebc1-446c-95f8-a5cfdbbbb530"},{"objectId":"659692b24097074a39029ffd","name":"Fernando","lastName":"Rivera","documentHash":"f4b15fda-e021-4a75-8596-9d010d8ecaf3"},{"objectId":"659692b24097074a39029ffc","name":"Jeeyun","lastName":"Lee","documentHash":"28b4b055-6518-4013-9171-2e1eb12b3d5f"},{"objectId":"659692b24097074a39029ffb","name":"Min-Hee","lastName":"Ryu","documentHash":"193ea2cc-410c-4609-a7ea-a877b473b02c"},{"objectId":"659692b24097074a39029ffa","name":"Yuxian","lastName":"Bai","documentHash":"6bf81db7-b8e3-4140-a640-2d39cb2fce06"},{"objectId":"659692b24097074a39029ff9","name":"Patricio","lastName":"Yañez","documentHash":"197dc704-8ca8-46b0-a900-2cc23c2e72af"},{"objectId":"659692b24097074a39029ff8","name":"Do-Youn","lastName":"Oh","documentHash":"4d0b5057-b00a-4172-b237-50162f220052"},{"objectId":"659692b24097074a39029ff7","name":"Sun Young","lastName":"Rha","documentHash":"18c3828d-871f-413a-826f-95a625d497c1"},{"objectId":"61ea28b875234061bbd3c299","name":"Łukasz","lastName":"Hajac","uuid":"EA26F3284EC4D1F80D0DC0B6348F0441522B1751634A9E957422A4EF155785849782886B72BBA743B7E22514666AFEC5A1119FD266DC15020395DC791D6CF60C","documentHash":"129252f0-3729-454f-a93d-cac93c928837"},{"objectId":"5e7093fb878c28a0473b458d","name":"Lucjan","lastName":"Wyrwicz","uuid":"1FA6D659E22940715FEB58E2425ABFA3C77D19D9113E38E51B62FF8523073EB2AFB1E60C848CF2ABF980407C5A1DA3BCDEDB71FCF82D62B4B5078903560FFA22","documentHash":"0a29283e-2d59-403b-a7ae-0c88ab733021"}],"objectId":"659692b24097074a39029ff5","doi":"10.1016/s1470-2045(23)00515-6","publicUri":"https://www.sciencedirect.com/science/article/pii/S1470204523005156?via%3Dihub","type":"ARTICLE","typeName":"Artykuł","year":2023,"title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Background: PD-1 inhibitors combined with chemotherapy have shown efficacy in gastric or gastro-esophageal junction cancer. We compared the efficacy and safety of pembrolizumab plus chemotherapy with placebo plus chemotherapy in participants with locally advanced or metastatic HER2-negative gastric or gastro-esophageal junction adenocarcinoma.\n\nMethods: KEYNOTE-859 is a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial, done at 207 medical centres across 33 countries. Eligible participants were aged 18 years and older with previously untreated histologically or cytologically confirmed locally advanced or metastatic HER2-negative gastric or gastro-esophageal junction adenocarcinoma and an Eastern Cooperative Oncology Group performance status of 0 or 1. Patients were randomly assigned (1:1) to receive pembrolizumab or placebo 200 mg, administered intravenously every 3 weeks for up to 35 cycles. All participants received investigator's choice of fluorouracil (intravenous, 800 mg/m2 per day) administered continuously on days 1-5 of each 3-week cycle plus cisplatin (intravenous, 80 mg/m2) administered on day 1 of each 3-week cycle or capecitabine (oral, 1000 mg/m2) administered twice daily on days 1-14 of each 3-week cycle plus oxaliplatin (intravenous, 130 mg/m2) administered on day 1 of each 3-week cycle. Randomisation was done using a central interactive voice-response system and stratified by geographical region, PD-L1 status, and chemotherapy in permuted block sizes of four. The primary endpoint was overall survival, assessed in the intention-to-treat (ITT) population, and the populations with a PD-L1 combined positive score (CPS) of 1 or higher, and PD-L1 CPS of 10 or higher. Safety was assessed in the as-treated population, which included all randomly assigned participants who received at least one dose of study intervention. Here, we report the results of the interim analysis. This study is registered with ClinicalTrials.gov, NCT03675737, and recruitment is complete.\n\nFindings: Between Nov 8, 2018, and June 11, 2021, 1579 (66%) of 2409 screened participants were randomly assigned to receive pembrolizumab plus chemotherapy (pembrolizumab group; n=790) or placebo plus chemotherapy (placebo group; n=789). Most participants were male (527 [67%] of 790 participants in the pembrolizumab plus chemotherapy group; 544 [69%] of 789 participants in the placebo plus chemotherapy group) and White (426 [54%]; 435 [55%]). Median follow-up at the data cutoff was 31·0 months (IQR 23·0-38·3). Median overall survival was longer in the pembrolizumab group than in the placebo group in the ITT population (12·9 months [95% CI 11·9-14·0] vs 11·5 months [10·6-12·1]; hazard ratio [HR] 0·78 [95% CI 0·70-0·87]; p<0·0001), in participants with a PD-L1 CPS of 1 or higher (13·0 months [11·6-14·2] vs 11·4 months [10·5-12·0]; 0·74 [0·65-0·84]; p<0·0001), and in participants with a PD-L1 CPS of 10 or higher (15·7 months [13·8-19·3] vs 11·8 months [10·3-12·7]; 0·65 [0·53-0·79]; p<0·0001). The most common grade 3-5 adverse events of any cause were anaemia (95 [12%] of 785 participants in the pembrolizumab group vs 76 [10%] of 787 participants in the placebo group) and decreased neutrophil count (77 [10%] vs 64 [8%]). Serious treatment-related adverse events occurred in 184 (23%) participants in the pembrolizumab group and 146 (19%) participants in the placebo group. Treatment-related deaths occurred in eight (1%) participants in the pembrolizumab group and 16 (2%) participants in the placebo group. No new safety signals were identified.\n\nInterpretation: Participants in the pembrolizumab plus chemotherapy group had a significant and clinically meaningful improvement in overall survival with manageable toxicity compared with participants in the placebo plus chemotherapy group. Therefore, pembrolizumab with chemotherapy might be a first-line treatment option for patients with locally advanced or metastatic HER2-negative gastric or gastro-esophageal junction adenocarcinoma."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c299"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"24","issue":"11","pagesFromTo":"1181-1195","articleEvaluation":{"indexedJournal":false,"isReview":false,"wosConference":false},"contributionOrder":{"AUTHOR":["659692b24097074a39029ff7","659692b24097074a39029ff8","659692b24097074a39029ff9","659692b24097074a39029ffa","659692b24097074a39029ffb","659692b24097074a39029ffc","659692b24097074a39029ffd","659692b24097074a39029ffe","659692b24097074a39029fff","659692b24097074a3902a000","659692b24097074a3902a001","659692b24097074a3902a002","659692b24097074a3902a003","659692b24097074a3902a004","659692b24097074a3902a005","659692b24097074a3902a006","659692b24097074a3902a007","659692b24097074a3902a008","659692b24097074a3902a009","659692b24097074a3902a00a","659692b24097074a3902a00b","659692b24097074a3902a00c","659692b24097074a3902a00e","659692b24097074a3902a00f","659692b24097074a3902a010","659692b24097074a3902a011","659692b24097074a3902a012","659692b24097074a3902a013","659692b24097074a3902a014","659692b24097074a3902a015","659692b24097074a3902a016","659692b24097074a3902a017","659692b24097074a3902a018","659692b24097074a3902a019","659692b24097074a3902a01a","659692b24097074a3902a01b","659692b24097074a3902a01c","659692b24097074a3902a01d","659692b24097074a3902a01e","659692b24097074a3902a01f","659692b24097074a3902a020","659692b24097074a3902a021","659692b24097074a3902a022","659692b24097074a3902a023","659692b24097074a3902a024","659692b24097074a3902a025","659692b24097074a3902a026","659692b24097074a3902a027","659692b24097074a3902a028","659692b24097074a3902a029","659692b24097074a3902a02a","659692b24097074a3902a02b","659692b24097074a3902a02c","659692b24097074a3902a02d","659692b24097074a3902a02e","659692b24097074a3902a02f","659692b24097074a3902a030","659692b24097074a3902a031","659692b24097074a3902a032","659692b24097074a3902a033","659692b24097074a3902a034","659692b24097074a3902a035","659692b24097074a3902a036","659692b24097074a3902a037","659692b24097074a3902a038","659692b24097074a3902a039","659692b24097074a3902a03a","659692b24097074a3902a03b","659692b24097074a3902a03c","659692b24097074a3902a03d","659692b24097074a3902a03e","659692b24097074a3902a03f","659692b24097074a3902a040","659692b24097074a3902a041","659692b24097074a3902a042","659692b24097074a3902a043","659692b24097074a3902a044","659692b24097074a3902a045","659692b24097074a3902a046","659692b24097074a3902a047","659692b24097074a3902a048","659692b24097074a3902a049","659692b24097074a3902a04a","659692b24097074a3902a04b","659692b24097074a3902a04c","659692b24097074a3902a04d","659692b24097074a3902a04e","659692b24097074a3902a04f","659692b24097074a3902a050","659692b24097074a3902a051","659692b24097074a3902a052","659692b24097074a3902a053","659692b24097074a3902a054","659692b24097074a3902a055","659692b24097074a3902a056","659692b24097074a3902a057","659692b24097074a3902a058","659692b24097074a3902a059","659692b24097074a3902a05a","659692b24097074a3902a05b","659692b24097074a3902a05c","659692b24097074a3902a05d","659692b24097074a3902a05e","659692b24097074a3902a05f","659692b24097074a3902a060","659692b24097074a3902a061","659692b24097074a3902a062","659692b24097074a3902a063","659692b24097074a3902a064","659692b24097074a3902a065","659692b24097074a3902a066","659692b24097074a3902a067","659692b24097074a3902a068","659692b24097074a3902a069","659692b24097074a3902a06a","659692b24097074a3902a06b","659692b24097074a3902a06c","659692b24097074a3902a06d","659692b24097074a3902a06e","659692b24097074a3902a06f","659692b24097074a3902a070","659692b24097074a3902a071","659692b24097074a3902a072","659692b24097074a3902a073","659692b24097074a3902a074","659692b24097074a3902a075","659692b24097074a3902a076","659692b24097074a3902a077","659692b24097074a3902a078","659692b24097074a3902a079","659692b24097074a3902a07a","659692b24097074a3902a07b","659692b24097074a3902a07c","659692b24097074a3902a07d","659692b24097074a3902a07e","659692b24097074a3902a07f","659692b24097074a3902a080","659692b24097074a3902a081","659692b24097074a3902a082","659692b24097074a3902a083","659692b24097074a3902a084","659692b24097074a3902a085","659692b24097074a3902a086","659692b24097074a3902a087","659692b24097074a3902a088","659692b24097074a3902a089","659692b24097074a3902a08a","659692b24097074a3902a08b","659692b24097074a3902a08c","659692b24097074a3902a08d","659692b24097074a3902a08e","659692b24097074a3902a08f","659692b24097074a3902a090","659692b24097074a3902a091","659692b24097074a3902a092","659692b24097074a3902a093","659692b24097074a3902a094","659692b24097074a3902a095","659692b24097074a3902a096","659692b24097074a3902a097","659692b24097074a3902a098","659692b24097074a3902a099","659692b24097074a3902a09a","659692b24097074a3902a09b","659692b24097074a3902a09c","659692b24097074a3902a09d","659692b24097074a3902a09e","659692b24097074a3902a09f","659692b24097074a3902a0a0","659692b24097074a3902a0a1","659692b24097074a3902a0a2","659692b24097074a3902a0a3","659692b24097074a3902a0a4","659692b24097074a3902a0a5","659692b24097074a3902a0a6","659692b24097074a3902a0a7","659692b24097074a3902a0a8","659692b24097074a3902a0a9","659692b24097074a3902a0aa","659692b24097074a3902a0ab","659692b24097074a3902a0ac","659692b24097074a3902a0ad","659692b24097074a3902a0ae","659692b24097074a3902a0af","659692b24097074a3902a0b0","659692b24097074a3902a0b1","659692b24097074a3902a0b2","659692b24097074a3902a0b3","659692b24097074a3902a0b4","659692b24097074a3902a0b5","659692b24097074a3902a0b6","659692b24097074a3902a0b7","659692b24097074a3902a0b8","659692b24097074a3902a0b9","659692b24097074a3902a0ba","659692b24097074a3902a0bb","659692b24097074a3902a0bc","659692b24097074a3902a0bd","659692b24097074a3902a0be","659692b24097074a3902a0bf","659692b24097074a3902a0c0","659692b24097074a3902a0c1","659692b24097074a3902a0c2","659692b24097074a3902a0c3","659692b24097074a3902a0c4","659692b24097074a3902a0c5","659692b24097074a3902a0c6","659692b24097074a3902a0c7","659692b24097074a3902a0c8","659692b24097074a3902a0c9","659692b24097074a3902a0ca","659692b24097074a3902a0cb","659692b24097074a3902a0cc","659692b24097074a3902a0cd","659692b24097074a3902a0ce","659692b24097074a3902a0cf","659692b24097074a3902a0d0","659692b24097074a3902a0d1","659692b24097074a3902a0d2","659692b24097074a3902a0d3","659692b24097074a3902a0d4","659692b24097074a3902a0d5","659692b24097074a3902a0d6","659692b24097074a3902a0d7","61ea28b875234061bbd3c299","5e7093fb878c28a0473b458d"]},"journal":{"objectId":"5e6f7d4e878c285145478c76","mniswId":"13428","title":"The Lancet Oncology","issn":"1470-2045","websiteLink":"http://www.journals.elsevier.com/the-lancet-oncology","documentHash":"8ac0b144-8a70-4fb3-a8f1-30ba7e08aa63"},"_version":4,"journalIssue":{"objectId":"659692b24097074a39029ff6","year":"2023","volume":"24","number":"11","documentHash":"3b649307-dc95-4648-a2a9-255c67968aab"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747654913152"},{"authors":[{"objectId":"67598337fdbe83757db55712","name":"Bożena","lastName":"Cybulska-Stopa","documentHash":"5f0c2b5c-fa9d-4f7b-b1fe-35a0a06d9139"},{"objectId":"67598337fdbe83757db55711","name":"Adam","lastName":"Maciejczyk","documentHash":"aa2f9828-859e-4058-917a-548f743faa2b"},{"objectId":"67598337fdbe83757db55710","name":"Martyna","lastName":"Hajac","documentHash":"88bf91d0-e685-471b-ba91-f7ea7c5dc432"},{"objectId":"67598337fdbe83757db5570f","name":"Lilianna","lastName":"Wisłocka-Rawson","documentHash":"9764b982-d807-4e38-bf5e-0db46a1043f1"},{"objectId":"67598337fdbe83757db5570d","name":"Marcin","lastName":"Sokołowski","documentHash":"1d395f8a-f70a-4e48-88f7-693fc796f00a"},{"objectId":"67598337fdbe83757db5570c","name":"Ryszard","lastName":"Marzec","documentHash":"95439086-400e-49bb-bc1f-fa199c63aac6"},{"objectId":"67598337fdbe83757db5570b","name":"Monika","lastName":"Migdał","documentHash":"ecdcecb1-328c-4eb4-a4b3-3df504365cae"},{"objectId":"67598337fdbe83757db5570a","name":"Anna","lastName":"Sroka","documentHash":"7f562aee-a752-47fd-99e0-ef3537ee26b0"},{"objectId":"67598337fdbe83757db55708","name":"Jakub","lastName":"Barczyk","documentHash":"11f53386-a7ff-4be7-8898-5a9874b965f0"},{"objectId":"67598337fdbe83757db55704","name":"Łukasz","lastName":"Tosik","documentHash":"88c1ce87-bb69-4ee3-8cb4-d668451e45ab"},{"objectId":"67598337fdbe83757db55702","name":"Katarzyna","lastName":"Tekiela","documentHash":"645599a0-33e1-493e-9979-151b5dc6dccc"},{"objectId":"61ea28b875234061bbd3c2a2","name":"Piotr","lastName":"Hudziec","uuid":"5F8D2BB42B32E87C31D212E407772124C23D2ABB806F2BCEE581EA84CBF607F9E68D2136A4B73ACCD8450BC229A9C99A6BE191C00F61B0F3028BE2682274EE59","documentHash":"d95b6378-9e9f-4ecd-ba8d-7b97d2331cad"},{"objectId":"61ea28b875234061bbd3c29b","name":"Natasza","lastName":"Kempa-Kamińska","uuid":"6E3454023C2C2F3D25688B923C8B056B97F4DFE25D4F4AFAC17ABB328F88D647843891BC939AD61FB738060BB7FA73279D0A0EB707FBB179CB03D976F6B48AD1","documentHash":"0027317f-2101-46a7-8721-38d17fe4a474"},{"objectId":"61ea28b875234061bbd3c299","name":"Łukasz","lastName":"Hajac","uuid":"EA26F3284EC4D1F80D0DC0B6348F0441522B1751634A9E957422A4EF155785849782886B72BBA743B7E22514666AFEC5A1119FD266DC15020395DC791D6CF60C","documentHash":"129252f0-3729-454f-a93d-cac93c928837"},{"objectId":"61ea28b875234061bbd3c285","name":"Maciej","lastName":"Różycki","uuid":"52BCED621FFCAA86746687A72FD94BA1598282C106759A8B49EDE1D6602E0C26BE9336C5B68D7702705EC931039AAD59600F950C7D03F156E4BB8F91CF60472F","documentHash":"f32e31c8-8166-4a8c-af2b-e636c1c2c2a7"},{"objectId":"61ea28b875234061bbd3c282","name":"Katarzyna","lastName":"Gabalewicz","uuid":"8DFA3B05A503BC5D4212C8B3E62EA2AEF491D3D739EDE3B29846F31EE9499353E75614AF1A40E972D413E5618FC67FD270BB5A86121DE22DDACD3C2FB8DE65FC","documentHash":"6c5eaf7c-771e-4d72-b95f-1cab88cecdad"},{"objectId":"61ea28b875234061bbd3c236","name":"Zbyszko","lastName":"Chowaniec","uuid":"54CC591F8C269EC4C57FC517848C3ABCF0564604C8025367083DE16B8EA54235FDC0526AFDA0CE64BCEFEC27374B88B0DA18311D9373455356958EC108176523","documentHash":"d5b87a0d-df08-4ad4-8a94-251085c4a374"},{"objectId":"61ea28b875234061bbd3c227","name":"Mateusz","lastName":"Malik","uuid":"E10C5FF6B24F9CB3F38E63DAE9909766E2F3D709424B581C90C3872E6FBE84412764D5FC8754E23364225C5F44C9D53E3CFAC24320E755E9F2A13213197E48D6","documentHash":"5b20b002-b90f-4ba9-a4a6-f02935e0ea43"}],"objectId":"67598337fdbe83757db556ff","doi":"10.1200/jco.2024.42.16_suppl.e15576","publicUri":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2024.42.16_suppl.e15576","type":"ARTICLE","typeName":"Artykuł","year":2024,"title":"Efficacy of trifluridine/tipiracil in 3rd or 4th line of treatment in patients with advanced or metastatic colorectal cancer: A real-world data analysis with subgroups exploration.","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"Patients with unresectable mCRC can achieve long-term overall survival (OS) thanks to modern systemic treatment and subsequent lines of therapy. With effective 1st, 2nd and next lines of therapy, their condition often allows further lines of treatment. Since publication of RECOURSE study, one of the most frequently used drugs in the 3rd or 4th line is trifluridine/tipiracyl (FTD/TPI). There is limited data on optimal selection of patients in order to obtain the greatest therapeutic gain with the least toxicity. The aim of this study was to find and define groups of patients who would benefit most from this treatment in a real-world mCRC patient population. Methods: Consecutive patients with unresectable or metastatic colorectal cancer (mCRC) started treatment with FTD/TPI between 1/Sep/2019 and 31/Dec/2023. Clinical factors including age, gender, primary location of colorectal cancer, BRAF, RAS and MSI-H status, ECOG performance status, baseline CEA level, location of metastases, response to treatment and AEs occurrence were analyzed. Survival analyses were performed using the Kaplan-Meier method, Log-rank and chi-square tests were used for comparison between groups. Data cut-off was 31/Jan/2024. Results: 822 medical records of patients with mCRC were analyzed. In total 261 patients treated with FTD/TPI were enrolled. 204 (78%) patients were treated with FTD/TPI in 3rd line (L3) and 57 (22%) in the 4th line (L4). Patients with RASmt were statistically more numerous in the L3 group; no other statistically significant differences in baseline characteristics was found between L3 and L4 groups. Estimated median OS (mOS) was 10.2 and 14.4 months in L3 and L4 group, respectively; no statistical significance was found between them (p = 0.0866; HR = 1.34, Cl 95% 0.9-1.9). Estimated median PFS (mPFS) was 7.4 and 4.6 months in L3 and L4 group, respectively, and statistically significant differences in mPFS was found in the L3 group in comparison to L4 (p = 0.0079; HR = 0.65, Cl 95% 0.5-0.9). Disease progression (PD) was found in 187 (92%) and 50 (88%) patients in the L3 and L4 group, respectively. PD was most common reason for discontinuing therapy. Most frequent serious AEs of grade 3 or higher were diarrhea, neutropenia and weakness. There were no grade 5 AEs and toxicity rarely led to discontinuation of FTD/TPI therapy. 102 (39%) patients were qualified for next line sequential systemic treatment after L3 or L4. Conclusions: Patients with mCRC who were treated with FTD/TPI in the 3rd line had better PFS than patients treated in 4th line, but mOS was statistically non-significantly better in L4 than L3, which requires further analysis. FTD/TPI is an effective therapy in subsequent lines of treatment for mCRC patients with acceptable toxicity."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c282","61ea28b875234061bbd3c285","61ea28b875234061bbd3c2a2","61ea28b875234061bbd3c236","61ea28b875234061bbd3c227"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"42","issue":"16_suppl","pagesFromTo":"e15576-e15576","articleEvaluation":{"indexedJournal":false,"isReview":true,"wosConference":false},"contributionOrder":{"AUTHOR":["61ea28b875234061bbd3c299","67598337fdbe83757db55702","61ea28b875234061bbd3c227","67598337fdbe83757db55704","61ea28b875234061bbd3c236","61ea28b875234061bbd3c29b","61ea28b875234061bbd3c285","67598337fdbe83757db55708","61ea28b875234061bbd3c2a2","67598337fdbe83757db5570a","67598337fdbe83757db5570b","67598337fdbe83757db5570c","67598337fdbe83757db5570d","61ea28b875234061bbd3c282","67598337fdbe83757db5570f","67598337fdbe83757db55710","67598337fdbe83757db55711","67598337fdbe83757db55712"]},"journal":{"objectId":"5e6f7d4d878c285145478574","mniswId":"10525","title":"Journal of Clinical Oncology","issn":"0732-183X","documentHash":"b45a9b08-b35b-457a-8d3d-58d2306ed5c5"},"_version":4,"journalIssue":{"objectId":"67598337fdbe83757db55700","year":"2024","volume":"42","number":"16_suppl","documentHash":"24fca812-6206-40ab-9a43-9af785aa1303"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747655045369"},{"authors":[{"objectId":"675a8b61fdbe834687b6663e","name":"Piotr","lastName":"Rutkowski","documentHash":"e0b0b390-1d10-4e9b-9624-f69ec48e18f1"},{"objectId":"675a8b61fdbe834687b6663d","name":"Jacek","lastName":"Mackiewicz","documentHash":"c2be4880-2882-45da-96ce-de4eb8202f05"},{"objectId":"675a8b61fdbe834687b6663c","name":"Rafał","lastName":"Suwiński","documentHash":"717dbaaf-36d4-42be-a6cc-99cc11d50a14"},{"objectId":"675a8b61fdbe834687b6663b","name":"Grazyna","lastName":"Kaminska-Winciorek","documentHash":"07b2c6fc-69cc-4e30-885c-1e7f552605de"},{"objectId":"675a8b61fdbe834687b6663a","name":"Pawel","lastName":"Rogala","documentHash":"00455df6-ff1a-4a90-86b0-47bbd64aa2a8"},{"objectId":"675a8b61fdbe834687b66639","name":"Tomasz","lastName":"Switaj","documentHash":"60112f56-dd7b-4e95-a679-3f9978194a29"},{"objectId":"675a8b61fdbe834687b66638","name":"Anna","lastName":"Surus-Hyla","documentHash":"b9a3bbf1-07e6-4eb0-a299-22df4a836922"},{"objectId":"675a8b61fdbe834687b66637","name":"Wieslaw","lastName":"Bal","documentHash":"52eb92be-e897-4aa2-b96b-f6fbdc4a84a2"},{"objectId":"675a8b61fdbe834687b66636","name":"Agnieszka","lastName":"Kamycka","documentHash":"f24c031d-7103-4f8f-9d8a-b8e0037736bb"},{"objectId":"675a8b61fdbe834687b66635","name":"Joanna","lastName":"Seredyńska","documentHash":"624780f4-6cf3-4343-acf0-4c833d07e6bb"},{"objectId":"675a8b61fdbe834687b66633","name":"Barbara","lastName":"Ziolkowska","documentHash":"7e474ee9-8e00-4102-a063-a44c711fe90d"},{"objectId":"675a8b61fdbe834687b66632","name":"Łukasz","lastName":"Galus","documentHash":"62435571-7307-4b89-a74a-b2a576532fb4"},{"objectId":"675a8b61fdbe834687b66631","name":"Ewa","lastName":"Rutkowska","documentHash":"65fca18e-d449-4917-ae5a-bf07238e9591"},{"objectId":"675a8b61fdbe834687b66630","name":"Robert","lastName":"Dziura","documentHash":"a7822658-0d62-4172-87c8-de40fd6c4662"},{"objectId":"675a8b61fdbe834687b6662f","name":"Marcin","lastName":"Zietek","documentHash":"17cb9617-b3c5-4ae5-8725-421bcb356c89"},{"objectId":"675a8b61fdbe834687b6662e","name":"Karolina","lastName":"Piejko","documentHash":"d9fac5ee-14be-4564-8763-56621b73b2e4"},{"objectId":"675a8b61fdbe834687b6662d","name":"Krzysztof","lastName":"Ostaszewski","documentHash":"57466b46-fbc0-4b2b-8b16-d3903c60f20b"},{"objectId":"675a8b61fdbe834687b6662c","name":"Anna Malgorzata","lastName":"Czarnecka","documentHash":"f0124221-0f4d-47ab-baaf-4913877180ae"},{"objectId":"675a8b61fdbe834687b6662b","name":"Bozena","lastName":"Cybulska-Stopa","documentHash":"f2ee221f-5afb-497d-9ad1-a0ea31a69414"},{"objectId":"61ea28b875234061bbd3c29b","name":"Natasza","lastName":"Kempa-Kamińska","uuid":"6E3454023C2C2F3D25688B923C8B056B97F4DFE25D4F4AFAC17ABB328F88D647843891BC939AD61FB738060BB7FA73279D0A0EB707FBB179CB03D976F6B48AD1","documentHash":"0027317f-2101-46a7-8721-38d17fe4a474"}],"objectId":"675a8b61fdbe834687b6662a","doi":"10.1200/jco.2022.40.16_suppl.e21539","publicUri":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2022.40.16_suppl.e21539","type":"ARTICLE","typeName":"Artykuł","year":2022,"title":"Sequential treatment with targeted and immune checkpoint inhibitor therapies in patients with BRAF positive metastatic melanoma: Real-world data.","otherTitles":[],"abstracts":[{"languageCode":"eng","content":"The use of targeted therapies (TT) and checkpoint inhibitors (IT) significantly prolonged survival in patients with metastatic melanoma, especially in patients with BRAF mutation-positive melanoma. Optimal sequence of therapies use is still a matter of debate. The aim of this study was to evaluate real-life practice and outcomes in melanoma patients treated sequentially."}],"affiliations":[{"id":"5e7091c2878c28a047388295","uid":"bYz8J4NLTqsU5rjhfBkckUg","uuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","name":"Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii","affiliatedPersonIDs":["61ea28b875234061bbd3c29b"],"parentId":"5e7091c2878c28a047388295","parentUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","rootId":"5e7091c2878c28a047388295","rootUuid":"9e5a9950-3d7f-4a04-9ba7-091fd2268870","type":"AUTHOR"}],"mainLanguage":"eng","mainLanguageName":"angielski","volume":"40","issue":"16_suppl","pagesFromTo":"e21539-e21539","articleEvaluation":{"indexedJournal":false,"isReview":true,"wosConference":false},"contributionOrder":{"AUTHOR":["675a8b61fdbe834687b6662b","675a8b61fdbe834687b6662c","675a8b61fdbe834687b6662d","675a8b61fdbe834687b6662e","675a8b61fdbe834687b6662f","675a8b61fdbe834687b66630","675a8b61fdbe834687b66631","675a8b61fdbe834687b66632","675a8b61fdbe834687b66633","61ea28b875234061bbd3c29b","675a8b61fdbe834687b66635","675a8b61fdbe834687b66636","675a8b61fdbe834687b66637","675a8b61fdbe834687b66638","675a8b61fdbe834687b66639","675a8b61fdbe834687b6663a","675a8b61fdbe834687b6663b","675a8b61fdbe834687b6663c","675a8b61fdbe834687b6663d","675a8b61fdbe834687b6663e"]},"journal":{"objectId":"5e6f7d4d878c285145478574","mniswId":"10525","title":"Journal of Clinical Oncology","issn":"0732-183X","documentHash":"b45a9b08-b35b-457a-8d3d-58d2306ed5c5"},"_version":4,"journalIssue":{"objectId":"63d64abf40970753829313c9","year":"2022","volume":"40","number":"16_suppl","documentHash":"9c11fd4f-7c42-43f1-ac0e-d46b29dafced"},"translation":false,"editors":[],"translators":[],"institutionProfile":true,"translationEditors":[],"keywords":[],"lastRefresh":"1747655045492"}]